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VE-cadherin/Cdh5 is a prominent adhesion protein located in endothelial adherens junctions. 
Amongst its many functions, Cdh5 is important for cell shape changes to generate multicellular 
vascular tubes. Analysis of cytoskeletal organisation and dynamics has led to a model, in which 
bipolar actin polymerisation drives junctional elongation between endothelial cells (ECs) via 
Cdh5. I now want to analyse the Cdh5 based cell interactions, which drive tube formation, more 
closely, by generating mosaic angiogenic sprouts in zebrafish that contain cells with different 
Cdh5 levels. Therefore, I generated as my main project an inducible Cdh5 loss of function 
allele, using Bacterial Artificial Chromosome (BAC) recombineering technology. Hereto, the 
exon 2 of a BAC containing the cdh5 gene was replaced by the Cdh5 open reading frame 
flanked by loxP sites, coupled to tagRFP to visualise its expression. Its subsequent introduction 
into the zebrafish genome led to expression of tagRFP at adherens junctions. Via expression of 
inducible Cre-recombinase (heat-shock or tamoxifen induced), this line will enable us to 
examine Cdh5 function at different time points during vascular development.  
In order to examine to what extend individual neighbouring ECs contribute to the formation of 
adherens junctions, I additionally generated as a photo-convertible fluorescence-tagged Cdh5, 
using BAC recombineering technology. Hereto, the sequence encoding for mClavGR2 was 
introduced between the p120-catenin and β-catenin binding sites of the translated Cdh5 protein. 
Micro-injection of this BAC resulted in junctional mClavGR2 expression in green, which was 
able to convert into red light emission. Via photo-conversion of single cells, this tool will allow 
the visualisation of Cdh5 derived from two different cells within the same adherens junction by 
emission of two different light rays (green and red). These tools will contribute to elucidate 
more about the dynamic endothelial cell behaviours underlying sprouting angiogenesis. 
Rap1 is a small GTPase and member of the Ras superfamily and predominantly involved in cell 
adhesion and junction. Ras-interacting protein 1 (Rasip1) is a Rap1 effector protein, highly 
expressed in endothelial cells and controlling the activity of RhoA, Rac1 and Cdc42, all 
important to Cdh5 remodelling and organisation. Its absence impairs proper Cdh5 localisation 
and lumen formation in blood vessels in mice and zebrafish. Research on cell culture showed 
that Rasip1 is not the only Rap1 effector, but cooperates with Ras-associating and dilute 
domain-containing protein (Radil). Contrary to the other Rap1-specific effectors, Radil’s 
mechanism of action is still unknown, although it shares three of its four protein domains with 
Rasip1. In this side project, genomic analysis showed three Radil paralogues (RadilA, -B and -
C) in the zebrafish genome, of which two are not annotated. In situ hybridisation for each Radil 
paralogue showed that RadilB was endothelial specifically expressed. RadilB KO fish 
developed crooked and dilated blood vessels, and show intermittent lumen collapse during 
vessel growth. Further analysis on growing intersegmental vessels (ISVs) in the absence of 
RadilB showed that the intermittent lumen collapse only takes place in arterial ISVs that convert 
to venous ISVs and simultaneously divide. In contrary to wild type, a shunt of blood flow from 
the dorsal aorta into the post cardinal vein sometimes appears during this transformational 
phase. Meanwhile, ISVs in RadilB knockout fish underwent less cell divisions and showed 
aberrant Cdh5 localisation. The closely-related endothelial specific proteins Rasip1 and RadilB 
form two important targets for research that will elucidate more about Cdh5 organisation 
controlled by small GTPases and consequently about Cdh5 remodelling-based EC behaviours. 
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1.1 Blood vessel formation 
 
An efficient transport and exchange of fluids, gasses, nutrients and blood cells requires 
extensive networks of blood and lymphatic vessels. The lumen of both systems is lined by 
endothelial cells (ECs). Blood vessels transport blood throughout the entire body, whereas 
lymphatic vessels transport extravasated fluid from the tissues back to the blood vessels. There 
are three major classes of blood vessels: arteries, capillaries and veins. Arteries are surrounded 
by multiple layers of smooth muscle cells and transport blood away from the heart. The 
endothelial walls of capillaries consist only of one cell layer, which allows exchange of gasses, 
nutrients and waste compounds with the surrounding tissue. Veins are valve containing vessels 
that transport the blood towards the heart. Mural cells comprise vascular smooth muscle cells 
and pericytes that are both involved in formation and maintenance of normal vasculature. 
Pericytes cover ECs and establish direct cell-cell contact with ECs, whereas vascular smooth 
muscle cells cover arteries and, too lesser extent, veins, to enable regulation of the calibre of 
the blood vessels (Adams and Alitalo, 2007). Development of these transport networks arises 
from three processes: vasculogenesis, angiogenesis and lymphangiogenesis. The cardiovascular 
system is the first functional organ that develops during embryogenesis. 
 
1.1.1. Vasculogenesis 
Vasculogenesis is the de novo formation of blood vessels from progenitor cells, called 
angioblasts. The first endothelial cells in zebrafish arise in two stripes in the posterior lateral 
mesoderm at around 13 hours post fertilisation (hpf). These endothelial precursor cells, known 
as haemangioblasts, migrate at 17hpf towards the embryonic midline where they coalesce into 
a vascular cord: the dorsal aorta (DA), the first tube with arterial cell fate (Torres-Vázquez et 
al., 2003; Jin et al., 2005). Shortly afterwards at 20hpf, the DA gives rise to the formation of 
the postcardinal vein (PCV) by ventral sprouting (Herbert et al., 2009). Most other blood vessels 
of the organism, however, will be formed by angiogenesis. 
 
1.1.2. Angiogenesis 
Angiogenesis is the extension of blood vessels from pre-existing vascular structures. In general, 
three main processes are involved: cell sprouting, anastomosis and lumen formation. 
 
1.1.2.1. Cell sprouting: tip cell selection and outgrowth 
When the supply of nutrients and oxygen from the existing vessels cannot satisfy the demands 
within a tissue, the tissue will send out signals to stimulate formation of new blood vessels 
(Germain et al., 2010). Vascular endothelial growth factor (Vegf) is an important angiogenesis 
promoting signal that activates the endothelium, resulting in the selection of a tip cell.  Although 
the Vegf receptors of all endothelial cells exposed to Vegf are activated, only a limited number 
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of cells will be selected to become a tip cell (Gerhardt et al., 2003). A Vegf/Notch dependent 
regulatory mechanism within the endothelium ensures the selection of a tip cell by blocking the 
neighbouring cells from developing into tip cells (Geudens and Gerhardt, 2011). VegfA/Vegfr2 
signalling results in enrichment of the Notch ligand delta like ligand 4 (Dll4) and its 
presentation on the membrane of the EC directed towards its neighbouring cells. The 
subsequent activation of Notch by Dll4 in the neighbouring cells, will suppress the expression 
of Vegf receptor 2 (Vegfr2, alternative names: Flk1 and Kdr), Dll4 and platelet-derived growth 
factor B (PDGFB), and promote the expression of soluble Vegf receptors (sFlt1). These changes 
in protein production will make the cell less sensitive to Vegf and decrease their ability to 
activate Notch in their neighbouring cells (Gerhardt et al., 2003). Consequently, the endothelial 
cell producing most Dll4 will grow out as the tip followed by its neighbours as stalk cells 
(Figure I-IA). In addition, sFlt1 has been found to be important for local sprout outgrowth 
guidance (Chappell et al., 2009).  
 
 
Figure I-I. Induction of sprouting. (A) Single endothelial cells will be selected as tip cell after 
activation by Vegf. Presentation of Dll4 to the neighbouring cells will suppress the expression of genes 
that make them less sensitive to Vegf stimulation. The selected tip cell spearheads the emerging sprout, 
using its filopodia to scan the environment for attractive and repulsive cues. The neighbouring cells will 
become the stalk or follower cells that elongate the sprout. (B) Outgrowth of a blood vessel sprout. Due 
to difference in the attractive and repellent cues, differences in sprout cell stimulation leads to tip cell 
competition. In some cases, the position of the tip cell can be taken over by another stalk cell. (C) Tip 
cells contact each other via their filopodia and establish a junctional ring. The cell membrane within this 
ring becomes apically polarized and forms a luminal pocket from which the lumen can be pushed 
through. Taken from Siekmann et al., 2013.   
A 
B 
C 
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Tip cell selection is followed by sprout guidance and outgrowth. The selected tip cell has to 
change its characteristics drastically to acquire an invasive and motile behaviour, including by 
the formation of filopodia. The tip cell migrates towards the VEGF gradient, followed by its 
neighbouring cells, which act as proliferating cells, known as stalk cells (Adams and Alitalo, 
2007). The outgrowth direction of the sprout is additionally guided by attractive and repulsive 
cues including netrins, class 3 semaphorins and SLIT proteins (Eichmann et al., 2005). In 
addition, Semaphorin-Plexin signalling ensures the proper endothelial abundance of sflt1, 
thereby repressing angiogenic potential of the growing sprout to ensure proper guidance 
(Zygmunt et al., 2011). A growing vascular sprout produces PDGFB that promotes the 
recruitment of supporting pericytes to ensure that the endothelium of the growing vessel 
stabilises sufficiently (Ando et al., 2016). The tip and stalk cell phenotype appeared to be 
plastic; stalk cells can overtake tip cells and former tip cells can migrate back to the base of the 
sprout (Figure I-IB). This kind of cell shuffling is transient and cyclic, as Notch signalling re-
establishes a mixed pattern of cells with high and low receptor levels (Jakobsson et al., 2010). 
 
1.1.2.2. Anastomosis and subsequent cell divisions 
During the next step of angiogenesis, sprout fusion and lumen formation have to occur. When 
the filopodia of two tip cells encounter each other, strong adhesive interaction and EC-EC 
junctional contacts have to be established in order to accomplish fusion of the two sprouts, 
known as anastomosis (Adams and Alitalo, 2007). From the moment the filopodia of two tip 
cells contact each other, junctional proteins, including Cdh5 and ZO1, are deposited upon the 
contact sites (Figure I-IC) and grow into a junctional ring. Within this junctional ring, 
podocalyxin, a sialoglycoprotein, gets localised in order to polarise the tip cells by forming an 
apical membrane. The activity of filopodia reduces and the surface of the apical membrane in 
the junctional ring increases. Subsequently, the elongation of the ring allows transcellular lumen 
to push through, thereby establishing a new, perfused blood vessel connection. Finally, cell 
rearrangement by cell splitting allows the initial unicellular tube to remodel into a more durable 
multicellular tube (Lenard et al., 2013). The process of anastomosis is summarised in figure I-
II.  
The lack of Cdh5 does not prevent anastomosis, therefore other adhesion molecules cooperate 
in establishing junctions. Esam (Endothelial cell-selective adhesion molecule) is a JAM (cf. 
section 1.2) whose presence is restricted to endothelium. Aggregation assays have shown that 
Esam can generate efficient cell contacts, but its knock-out in mice and zebrafish does not lead 
to vascular defects (Hirata et al., 2001; Ishida et al., 2003). However, the combination of esam 
and cdh5 mutant alleles aggravates the single Cdh5 mutant phenotype, including the 
maintenance of filopodial contacts prior to anastomosis as well as the subsequent assembly of 
ECs into an organised endothelium, suggesting that both proteins are redundant during blood 
vessel morphogenesis (Sauteur et al., 2017). 
During spout outgrowth and after anastomosis, individual endothelial cells undergo division in 
order to overcome the distances between new established vessel connections. During cell 
division, ECs within a growing vessel undergo mitotic rounding, followed by symmetrically 
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cell furrowing and pinching of the cell body at the plane of division. During the division of 
unicellular cells, the lumen collapses in the plane of mitosis and reopens whenever the division 
process has been accomplished. Mitosis within multicellular tubes, however, does not lead to a 
lumen collapse (Aydogan et al., 2015). 
 
 
Figure I-II. Overview of blood vessel anastomosis. At the contact site of filopodia from two different 
sprouts, junctional proteins are deposited, which stabilises the contact site and grow out into a junctional 
ring. The surface of the functional ring gets polarised by the apical protein podocalyxin and its 
enlargement allows push though of the lumen between both cells. Cellular rearrangements changes the 
newly formed vessel from a unicellular into a multicellular configuration. Taken from Lenard et al., 
2013. 
__________________________________________________________________________________ 
 
1.1.2.3. Lumen formation 
Upon anastomosis, the tip cells lose their tip cell features, including their filopodia. 
Subsequently, a lumen within the sprout forms to allow blood flow. Lumen formation can occur 
by different mechanisms, such as intracellular vacuole coalescence, where ECs form 
intracellular vacuoles that fuse with each other generating a lumen. But also intracellular 
vacuole exocytosis can facilitate lumen formation, as well as luminal repulsion, where CD34-
sialomucins is localised to the cell-cell contact site and its negative charge induces electrostatic 
repulsion of the opposing EC surfaces (Ellertsdóttir et al., 2010; Strilić et al., 2010). After 
perfusion is established and ECs are matured, a new blood vessel is formed that improves 
oxygen delivery and consequently reduces pro-angiogenic signals from the tissue.  
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The two main mechanisms for lumen formation in zebrafish are cord hollowing and membrane 
invagination. Lumen formation by cord hollowing is driven by cell rearrangements in which 
cell contacts between at least three ECs generate two junctional rings that convert towards each 
other. In this case, both luminal pockets are brought towards each other and fuse into a lumen. 
By this mechanism, tubes become multicellular, but blood flow is not required (Figure I-IIIA). 
The majority of the vessels, however, form their lumen via membrane invagination for which 
less migration of the ECs is required, nor is the presence of continuous junctions demanded. In 
this case, the lumen extends through a single cell between two separate sites of contact. Blood 
pressure pushes the apical membrane through the cell body creating a unicellular tube with a 
transcellular lumen (Figure I-IIIB) (Herwig et al., 2011). Research on the formation of the 
common cardinal veins revealed a third mechanism of lumen formation, called lumen 
ensheathment. During this process, endothelial cells delaminate and align along an existing 
luminal space, extend via migration and eventually enclose the lumen (Helker et al., 2013). 
 
 
Figure I-III. Lumen formation by cord hollowing and membrane invagination. (A) During cord 
hollowing, two junctional rings convert towards each other by cellular rearrangement, leading to the 
fusion of both luminal pockets into a lumen in a multicellular tube. (B)  During membrane invagination, 
the lumen extends through a single cell between two separate sites of contact, whereupon blood flow 
pushes the apical membrane through the cell body creating a unicellular lumenised tube. Taken from 
Herwig et al., 2011. 
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1.1.2.4. Secondary sprouting in the zebrafish trunk 
For most analyses on sprouting angiogenesis and maturation, the development of the 
intersegmental vessels (ISVs) within the zebrafish trunk are used as a model, because of their 
metameric organisation and relatively simple anatomy (Ellertsdóttir et al., 2010). As most other 
forming blood vessels, they sprout, anastomose and form their lumen as describes so far. In 
more detail, ISVs derive from arterial precursors within the dorsal aorta and sprout dorsally 
around the neural tube and the notochord. At the dorsal side, they anastomose with their 
neighbouring sprouted ISVs thereby forming the dorsal longitudinal anastomotic vessel 
(DLAV) at around 30hpf (Figure I-IVA) (Isogai et al., 2003). 
Venous ISVs and the intersegmental lymphatics, however, are formed by a process called 
secondary sprouting. At around 32hpf, bipotential Prox1-positive precursors within the PCV 
divide and develop either a venous or a lymphatic fate. Their identities are established 
asymmetrically in daughter cells where the up-regulation of prox1 gives rise to a lymphatic cell, 
whereas down-regulation of prox1 preserves the venous identity (Koltowska et al., 2015). 
Around 36hpf, both precursors sprout along the ISVs to form either lymphatic ISVs or 
anastomose around 50hpf with the existing arterial ISV respectively, thereby in the latter case 
changing the initial artery into a vein (Isogai et al., 2003).  Simultaneously, the lymphatic 
sprouts continue migrating along the arterial ISVs and subsequently along the DLAV. At 
around 5dpf the lymphatic sprouts anastomose forming the thoracic duct (Hogan et al., 2009). 
 
Figure I-IV. Secondary sprouting in the zebrafish trunk to develop intersegmental veins and 
lymphatics. (A) At around 32hpf, bipotential precursors within the PCV divide and develop either a 
venous (blue arrow) or a lymphatic fate (green arrow). (B) Around 36hpf, both precursors sprout along 
the ISVs, indicated as secondary sprouting (C) At 50hpf, the venous secondary sprout (blue) 
anastomoses with the existing arterial ISV (red) thereby changing the initial artery into a vein. (D) The 
11 
 
lymphatic sprouts continue to migrate along the arterial ISVs and subsequently along the DLAV. At 
around 5dpf the lymphatic sprouts anastomose. DLAV dorsal longitudinal anastomosing vessel, ISV 
intersegmental vessel, PCV post cardinal vein. Adapted from Hogan and Schulte-Merker, 2017. 
__________________________________________________________________________________ 
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1.2 Endothelial cell junctions 
 
Most blood vessels develop by sprouting from pre-existing blood vessels in a process called 
angiogenesis (cf. 1.1.2.). During angiogenesis, endothelial cells need to reconcile two opposing 
challenges: during sprouting, anastomosis and lumen formation the cells have to be motile to 
change location, mutual position and cell shape whilst maintaining the permeability barrier and 
vascular integrity of the blood vessel. To this purpose, endothelial cells have several classes of 
cell-cell junctions at their disposal, from which adherens junctions and tight junctions are the 
most important ones. These junctions consist of adhesion mediating proteins, including vascular 
endothelial cadherin (Cdh5) forming adherens junctions, and claudins, occludins, junctional 
adhesion molecules (JAMs), endothelial selective adhesion molecule (ESAM) and nectins 
composing tight junctions. Further transmembrane proteins include amongst others PECAM-1 
and CD146 (Szymborska and Gerhardt, 2018). In general, adherens junctions initiate and 
maintain cell-cell contacts whereas tight junctions regulate the passage of ions and solutes 
between cells (Bazzoni and Dejana, 2004).  
In vitro studies have shown that Cdh5 plays an important role in various aspects related to 
endothelial cell biology, including regulation of EC adhesion, motility, shape, intracellular 
signalling and sensation of mechanical forces (Conway et al., 2013; Dejana and Vestweber, 
2013). However, the in vivo roles of Cdh5 enabling ECs to form stable blood vessels are less 
understood.  
 
1.2.1. The structure of vascular endothelial cadherin 
Amongst the several classes of cadherins, Cdh5 is restricted to endothelial cells. Cdh5 is a 
single-pass transmembrane protein, which mediates homophilic, calcium-dependent adhesion. 
The extracellular domain of Cdh5 contains five cadherin repeats and the intracellular domain 
attaches the cadherin to the cytoskeleton, but also interacts with other cytoplasmic proteins 
(Figure I-V).  Cadherin repeats can bind in cis and in trans to a neighbouring cadherin based on 
the calcium-dependent homophilic interaction of a conserved tryptophan residue at their amino-
terminal end. Adhesion between cells are established by promotion of the homophilic 
interactions that form a pericellular zipper-like structure along the cell border (Bazzoni and 
Dejana, 2004).  
The intracellular domain contains binding sites for proteins that regulate intracellular signalling 
(cf. section 1.3.1. on Rasip1) and two catenin-binding sites. One of these catenin-binding 
domains binds β-catenin at the distal C-terminus of Cdh5 and the other domain closer to the 
transcellular domain binds p120-catenin (Figure I-V). β-Catenin is also present in its free form 
in the cytoplasm and nucleus and can bind TCF/LEF transcription factor regulating cell 
proliferation (Klaus and Birchmeier, 2008). Multiple phosphorylation events regulate β-
catenin’s binding to Cdh5, where it serves as a scaffold recruiting cytoskeletal-associated 
proteins and α-catenin (Mateer et al., 2004). α-Catenin links the actin cytoskeleton to the 
adherens junction by binding on one hand to Cdh5-bound β-catenin and simultaneously to actin 
filaments in a 1:1:1:1 complex (Rimm et al., 1995). Plakoglobin (γ-catenin) has a similar 
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function as its homologue β-catenin and can also bind α-catenin. p120-Catenin stabilises Cdh5 
by its electrostatic and hydrophobic properties. In addition, its binding masks residues 
implicated in chlathrin-mediated endocytosis and ubiquitination (Ishiyama et al., 2010).  
 
 
Figure I-V. Schematic representation of Cdh5 and its interaction with the cytoskeleton. Trans 
binding of the extracellular cadherin repeats provides adhesion between the Cdh5-based adherens 
junctions of neighbouring cells. In addition, Cdh5 connects as a scaffold to the actin cytoskeleton of 
neighbouring cells by binding actin via α-catenin and β-catenin or plakoglobin to the intracellular 
domain of Cdh5. p120-Catenin stabilises Cdh5. Taken from Vincent et al., 2004. 
__________________________________________________________________________________ 
 
1.2.2. Mechano-transduction by Cdh5 
Endothelial cells are constantly exposed to changes in mechanical forces, including forces from 
pulsatile blood flow, vessel wall contractions and trafficking of immune cells. ECs are perfectly 
capable of adapting to these force changes whilst maintaining the vascular barrier function and 
integrity. Cdh5-based adherens junctions increase junction size without a loss of tension when 
a mechanical pulling force is exerted (Liu et al., 2010). In vitro switching between stable (linear) 
junctions and remodelling (perpendicular) junctions induced by pulling forces on the Cdh5 is 
controlled by small GTPases that modulate cytoskeletal dynamics. As an example, Rac1 
induces release of Cdh5 tension by supporting junctional stabilisation (Timmerman et al., 
2015). On the contrary, activation of Rho increases acto-myosin contractility and promotes that 
way the formation of remodelling junctions (Liu et al., 2010).  
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Cell culture experiments showed that F-actin connection to α-catenin can also be stabilised by 
the recruitment of vinculin to the adherens junction, which binds to α-catenin whenever acto-
myosin contractile forces are sensed and prevents junctions from opening too far (Le Duc et al., 
2010). Meanwhile, actin remodelling proteins including zyxin, VASP and TES are recruited to 
the actin fibre under tension (Figure I-VI) (Dorland and Huveneers, 2017). EPLIN is only 
observed in vinculin-free adherens junctions, which suggest its involvement in force-dependent 
regulation of Cdh5 opposite to vinculin (Taguchi et al., 2011). Junctional remodelling enables 
the endothelial cells to adapt to changing forces, induced e.g. by thrombin, Vegf or histamine 
stimuli, in order to maintain the vascular barrier of the blood vessel and individual cell integrity. 
 
Figure I-VI. Mechano-transduction events during remodelling of endothelial adherens junctions. 
In absence of force on Cdh5, the small GTPase Rac1 is active and controls the linear configuration of 
adherens junctions. At the moment mechanical force on the F-actin-Cdh5 complex is exerted, 
recruitment of vinculin and actin remodelling proteins takes place, induced by thrombin/Vegf/histamine 
signalling. Meanwhile Rho gets activated and induces the remodelling of the adherens junctions in 
perpendicular configuration. Both events stabilising the F-actin-Cdh5 connection and ensures 
endothelial cell barrier function and integrity. Taken from Dorland and Huveneers, 2017. 
__________________________________________________________________________________ 
 
In order to explore tensile changes exerted on Cdh5 in zebrafish, a Cdh5 tension sensor 
construct has been designed and initially introduced into VE-cadherin mutant HUVECs 
(Conway et al., 2013). To investigate tensional forces on Cdh5 in vivo, the same tension sensor 
module has been cloned into the zebrafish Cdh5 cDNA. In this bacterial artificial chromosome 
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(BAC) construct, a donor fluorescent protein Teal and an acceptor protein Venus, separated by 
a TV40 stretchable peptide, were introduced in the Cdh5 intracellular domain between the p120 
and β-catenin binding sites (Figure I-VII). Proximity of both proteins could be measured by 
Förster resonance energy transfer (FRET), indicating whether Cdh5 is under tension or not. 
Introduction of the Cdh5-tension-sensor containing BAC into Cdh5 mutants could rescue the 
phenotype and compensate the loss of endogenous Cdh5 at wild type levels. This tool showed 
release of actomyosin contraction by ROCK inhibition, maturation of the dorsal aorta and a 
decrease of calcium signalling decreases Cdh5 tension. Interestingly, acute loss of blood 
pressure did not alter the tension on Cdh5 (Lagendijk et al., 2017). 
 
 
Figure I-VII. Design of the Chd5 tension-sensor line. Between the p120 and β-catenin binding sites, 
a donor fluorescent protein Teal and an acceptor protein Venus separated by a TV40 stretchable peptide 
were introduced by BAC recombineering. The distance between both fluorophores can be measured by 
FRET, which serves as read-out for tension upon Cdh5. Taken from Lagendijk et al., 2017. 
__________________________________________________________________________________ 
 
1.2.3. Junctional remodelling in angiogenesis 
In order to enable cell rearrangement and cell shape changes necessary for the formation of 
stable blood vessels, dynamic regulation of junctional actin is required. Absence of Cdh5 in 
Cdh5 null-mutants led to continuous sprouting activity upon tip cell contact, thereby impeding 
anastomosis (Lenard et al., 2013). In the zebrafish trunk, the formation of a tip cell as well as 
its outgrowth were not perturbed, however, tip cells failed to organise themselves into the 
DLAV. Moreover, the formed ISVs comprised of unicellular tubes with discontinues tight 
junctions and lumens. Neither junctional elongation, nor remodelling into multicellular tubes 
took place within Cdh5-deprived ISVs. (Sauteur et al., 2014). These observations showed that 
Cdh5 is required for cell rearrangement necessary to obtain multicellular tubes. Perturbation of 
the Cdh5-actin link by either inhibiting F-actin polymerisation or knock-out of β-catenin led 
also to defects in lumen formation and maintenance, stressing the importance of Cdh5 as an 
actin-cytoskeleton anchor (Cattelino et al., 2003; Sauteur et al., 2014). These findings led to a 
model in which the transmission of a deforming force by Cdh5 in stalk cells promote cell 
elongation. To this purpose, junctions need to be elongated, which is driven by actin 
polymerisation that uses Cdh5 as an anchor point (Figure I-VIII). 
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Figure I-VIII. Schematic overview of the model concerning the role of Cdh5 in angiogenesis.  
Sprouting of ISVs and their anastomosis into the DLAV is followed by cell elongation and cellular 
rearrangement into a multicellular blood vessel. In absence of Cdh5, cell elongation and remodelling 
does not take place, due to the inability of actin polymerisation that uses Cdh5 as an anchor point, to 
exert its deforming force onto the adherens junction. The left panel shows a close-up of a junction-based 
lamellipodium (JBL) at the distal end of Cdh5 junctional ring at the border between two endothelial 
cells. Adapted from Sauteur et al., 2014. 
___________________________________________________________________________ 
 
Analysis of junctional rings in the DLAV in more detail, using the Cdh5 tension sensor line (cf. 
1.2.2.) to visualise Cdh5, revealed that in unicellular vessels the junctions were not uniform. 
Junctions were significantly thicker at the medial region than at the lateral side (Figure I-VIII, 
red frame on the left panel) coinciding with the direction of endothelial cell movement. Time 
lapse imaging of adherens junctions showed that these junctional thickenings were highly 
dynamic and behaved like lamellipodial protrusions, hence their name junction-based 
lamellipodia (JBL). Spatio-temporal analyses of JBLs as well as tight junctions allowed the 
description of how ECs move along each other by a, to actin-linked, Cdh5-based mechanism 
(Figure I-IX). In this model, actin polymerisation first forms a protrusion at the distal end of 
the junction which is followed by the establishment of a new junction at the anterior edge of 
the protrusion. Subsequently, the proximal junction is then pulled towards the anterior junction, 
leading to an elongation of the junctional ring. This mechanism allows endothelial cells to move 
along each other, change their shape and attain a multicellular configuration (Paatero et al., 
2018).  
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Figure I-VIII. Model of JBL-based endothelial cell movement. In order to allow EC movements 
whilst maintain the vascular barrier and vessel integrity, actin protrusions emanate distally form the 
existing junction and is followed by Cdh5 and ZO1 (component of tight junctions) accumulation at the 
new end of the protrusion, visible as JBLs. Finally, the proximal junction is pulled towards the distal 
end of the JBL and the cycle can start again. Cdh5 is visualised in green, ZO1 in red and F-actin in blue. 
Taken from Paatero et al., 2018. 
___________________________________________________________________________ 
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1.3 Control of small GTPase activity in endothelial cells by Rasip1 and 
Radil 
 
Cdh5 as the glue between endothelial cells and as a mechano-transducer of forces via its 
connection to the actin cytoskeleton, makes this protein indispensable for proper EC 
rearrangements without causing leakiness of the blood vessel. Actin polymerisation itself, as 
main contributor to force exertion via Cdh5, is also subjected to further regulation. F-actin can 
be polymerised (induced by e.g. ARP2/3 and formins), disassembled (by e.g. gelsolin and 
profilin) and contracted (by myosin), which are controlled by small GTPases. Small GTPases 
are a family of hydrolase enzymes that can bind and hydrolyse guanosine triphosphate (GTP). 
They are activated by guanine nucleotide exchange factors (GEFs) that exchange GDP for GTP. 
Deactivation takes place by the opposite process executed by GTPase activating proteins 
(GAPs). Via this system, small GTPases can be switched on and off, which makes them 
valuable regulators of various processes in the cell, including growth, cellular differentiation, 
cell movement and lipid vesicle transport (Cherfils and Zeghouf, 2013). 
Examples of small GTPases are RhoA (Ras homolog family member A) that induces acto-
myosin contraction and remodelling of junctions (cf. 1.2.2.), Rac1 (Ras-related C3 botulinum 
toxin substrate 1) that induces F-actin polymerisation and linearization of Cdh5 (cf. 1.2.2.) or 
Cdc42 (Cell division cycle 42) another important organiser of the cytoskeleton. In addition, 
inhibition of Rac1 leads to longer duration of JBLs (less dynamic) and consequently to a 
reduction in speed of junction elongation during DLAV anastomosis (Paatero et al., 2018). 
Activation of both Cdc42 and Rac1 are required for lumen formation in 3D collagen matrix 
assays (Iruela-Arispe and Davis, 2009). All these small GTPases belong to the Ras superfamily, 
the best documented family of small GTPases (Figure I-IX). However, not much is known about 
the regulation of small GTPases in endothelial cells yet. The only known EC specific regulating 
protein that controls members of the Ras superfamily is Rasip1 (Xu et al., 2011; Wilson et al., 
2013). 
 
Figure I-IX. Ras superfamily of small GTPases. Taken from Khan, 2009. 
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1.3.1. Regulation of endothelial cell stability and lumen formation by Rasip1 
Rasip1 was identified in a screen for potential effectors of Ras proteins (Mitin et al., 2004). A 
yeast two-hybrid system was performed using a Gal4-DNA-binding-domain-Ras-fusion protein 
as a bait and a human skeletal muscle cDNA library as the source of interacting proteins. 
Sequence analyses of the clones found five clones containing partial cDNA sequences that did 
not match to genes encoding for Ras effectors known at that time. These five clones represented 
cDNA that belonged to the same protein, but sequence comparison to the GenBank nucleotide 
databank did not match with an annotated gene. Since this protein was found as a Ras effector, 
it was named Rain (Ras interacting). Rain’s protein sequence contained a Ras-associating 
domain homologous to other Ras effectors, where the GTP-loaded form of Ras could bind, and 
a dilute domain that can bind to class V myosins, important for vesicular transport (Mitin et al., 
2004). The NCBI registered the annotation under the name Ras-intereacting protein 1 (Rasip1). 
In a microarray screen that transcriptionally profiled embryonic aortal ECs, Rasip1 was 
identified as a potential regulator of blood vessel development (Xu et al., 2009). Expression 
analysis by in situ hybridisation on mouse embryos showed that Rasip1 was initially expressed 
within the embryonic vascular plexus, but after mouse embryonic day E10.5 in growing blood 
vessels and postnatal in mature endothelium. Interestingly, Rasip1 expression was absent in 
vascularless Vegfr2 mutant mouse embryos and knock down by siRNA prevents angiogenesis 
of ECs in wound-healing assays. This was the first evidence that Rasip1 is required in the 
endothelium of embryonic vasculature (Xu et al., 2009). 
Other binding partners of Rasip1 were found by affinity purification and mass spectrometry 
using expression of FLAG-tagged Rasip1in endothelial cell lines (Xu et al., 2011). Rasip1 was 
able to bind non-muscle myosin heavy-chain IIA (NMHCIIA) as well as a RhoA-specific GAP 
called Arhgap29. Rasip1 knock-out mice were embryonic lethal and failed to develop lumens 
in all blood vessels. SiRNA knock down of either Rasip1 or Arhgap29 in vitro showed that both 
individual proteins were required for lumen formation, activation of Cdc42 and Rac1, and 
repression of RhoA (Western blot) (Xu et al., 2011).  
In order to further investigate the in vivo role of Rasip1, another Rasip1 knock-out mouse was 
generated by a different research group (Wilson et al., 2013). These mouse embryos were 
smaller in size, showed severe haemorrhages throughout the whole body, developed pericardial 
oedema and did not survive after E10.5. Vascular lumens were formed, but ultimately 
collapsed. In the same study, knock down of Rasip1 in zebrafish allowed blood circulation 
through the DA and PCV, however, the diameter of both vessels were irregular and smaller. 
Subsequent antibody stainings against Rasip1 showed a cytoplasmic pattern in HUVECs, but 
at newly forming or remodelling Cdh5-based adherens junctions, Rasip1 showed a junctional 
localisation. GST pull-down assays demonstrated direct physical interaction of Rasip1 with 
Rap1 (a Ras small GTPase known to increase EC barrier function), but not with RhoA, Rac1 
and Cdc42. Indeed, knock down of Rasip1 in HUVECs phenocopied the loss of Rap1 (or its 
GEF Epac1) by altering junctional actin organisation and junctional remodelling (Wilson et al., 
2013). 
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The binding partner of Rasip1, which is essential to be present for junctional localisation is 
Heart of Glass 1 (Heg1) (Kreuk et al., 2016). Heg1 is a transmembrane receptor essential for 
cardiovascular development that also binds via its cytoplasmic domain to Krit1 (or CCM1). 
Krit1 can bind Rap1 and associates with Cdh5 via β-catenin (Glading et al., 2007). Upon Rap1 
activation, Krit1 localises at adherens junctions where it directly interacts with Heg1. Since the 
cytoplasmic domain of Heg1 is highly conserved, but Krit1 requires only 10% of the tail, other 
Heg1 interactors were searched. Lysates of Heg1-biotin-tagged expressing HUVEC 
(endothelial) and HeLa (cervical cancerous) cells were analysed by mass spectrometry and 
yielded Rasip1 as a protein binding in HUVEC cells, but not in HELA cells, confirming its 
endothelial specific expression. Knock down of Heg1 and activation of Rap1 did not result in 
junctional localisation of Rasip1 indicating that Heg1 is required for Rasip1 localisation at the 
junction. Further, binding affinity, measured using FLAG-tagged Rasip1 constructs for three 
putative Rasip1 protein domains, showed that only a third domain, called forkhead domain, is 
sufficient for Heg1 binding (Figure I-X) (Kreuk et al., 2016). 
To investigate the role of Rasip1 at later embryonic stages than E10.5, an inducible Rasip1 
knock-out line based on tamoxifen-induced Cre-loxP recombination (cf. section 1.5), was 
generated. This line showed that Rasip1 is essential for blood vessel formation and maintenance 
in the mouse embryo, but is dispensable in quiescent adult vessels (Koo et al., 2016). The 
inducible Rasip1 knock out line was then crossed into mouse lines that could undergo Cre-loxP 
inducible ablation of RhoA and Cdc42. Ablation of Cdc42 led to blockage of vascular lumen 
formation, whereas the absence of RhoA led to larger vessel diameters, which could be 
phenocopied by ROCK (target of RhoA) inhibition. Deletion of Arhgap29 allowed normal 
tubulogenesis although the lumen stayed narrower, confirming its deactivating function on 
RhoA. These observations demonstrated that Rasip1 functions upstream of Cdc42 and RhoA. 
Moreover, these findings show that Rasip1 promotes Cdc42 activity in order to induce lumen 
formation and once the lumen is open, Rasip1 suppresses actin-myosin contractility in order to 
expand vessel lumens during embryonic growth (Barry et al., 2016).  
 
1.3.2. Discovery of Radil as a homologue of Rasip1 
Radil was discovered as a novel human protein in a screen for genes induced by an oncogenic 
translocation in a paediatric sarcoma. This protein was encoded by 1075 amino acids, including 
a Ras associating domain (RA), a Dilute domain (DIL) and a PDZ domain at the C-terminus 
(Smolen et al., 2007). The PDZ, which is not present in Rasip1, is named after the initials of 
the first three proteins in which the PDZ was found: post synaptic density protein (PSD95), 
Drosophila disc large tumour suppressor (Dlg1) and Zonula occludens-1 (ZO-1). Proteins 
containing PDZ domains are known to play important roles in anchoring receptor proteins in 
the membrane to the cytoskeleton (Lee and Zheng, 2010). Immuno-precipitation using FLAG-
tagged Radil (RA and DIL domain containing protein) showed that Radil preferentially binds 
to the small GTPase Rap1, but not to Cdc42 and Rac1. Further in situ hybridisation in zebrafish 
demonstrated a ubiquitous expression for Radil with an enrichment in the anterior part of the 
embryo. Knock down of Radil led to a diminished migratory capacity of neural crest (NC) cells 
leading to multiple defects in NC-derived lineages e.g. cartilage, pigment cells and enteric 
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neurons (Smolen et al., 2007). Later, RadilB was found to bind Arhgap29 in a mass 
spectrometry analysis (Ahmed et al., 2012). 
The physiological relevance of the Rap1-Rasip1-Arhgap29 signalling pathway was investigated 
in more detail by measuring the endothelial barrier (by electrical cell impedance sensing) of 
HUVECs. Depletion of Rasip1 reduced the basal endothelial barrier function, however, to a 
lesser extent than depletion of Arhgap29, suggesting that Rasip1 is not the only mediator of 
Arhgap29. Subsequently, depletion of both Rasip1 and Radil reduced the endothelial barrier 
resistance to a similar level as Arhgap29 depletion, even after overexpression of Rap1 (Post et 
al., 2013). Upon activation of Rap1 with the Epac1-selective activator 007-AM, GFP-
Arhgap29, GFP-Rasip1 and GFP Radil redistributed from the cytosol to the plasma membrane 
of HUVECs. Rasip1 translocalisation upon Rap1 activation was unaffected by knock down of 
Radil and vice versa, indicating that both proteins independently bind Rap1 through their own 
RA domain and translocate to the membrane independently. Arhgap29’s translocation, 
however, was dependent on Radil, but not on Rasip1. Truncated Radil lacking its PDZ domain, 
could not translocate Arhgap29, indicating that upon Rap1 activation, Radil binds Arhgap29 
via the PDZ domain and then translocates to the cell membrane (Post et al., 2015). Since Rasip1 
does not possess a PDZ domain, its binding to Arhgap29 was most probably found in a Rasip1-
Radil-Arhgap29 complex, where Arhgap29 indirectly bound to Rasip1 via Radil (cf. Xu et al., 
2011). My interpretation of the available data concerning Rasip1 and Radil is summarised in 
figure I-XB. 
 
 
Figure I-X. Interpretation of Rasip1 protein domain functions and Rasip1/Radil working 
mechanism based on available literature. (A) Domains of Rasip1 with indicated binding partner. (B) 
Working mechanism of Rap1-Rasip1-RhoA signalling. Upon activation of Rap1 by its GEF Epac1, 
GTP-bound Rap1 binds Radil and Rasip1 that subsequently translocate towards the junctions. 
Meanwhile, Rap1-bound Radil binds the RhoA-specific GAP Arhgap29 and binds simultaneously with 
Rasip to the cytosolic tail of Heg1. This protein complex is linked via Krit1 (or CCM1) to β-catenin at 
the intracellular tail of Cdh5 and inhibits RhoA activity. RhoA is an activator of ROCK, which induces 
actin-myosin contraction by non-muscle myosin II (NM-II). 
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1.4 Introduction to BAC recombineering 
 
Bacterial Artificial Chromosomes (BAC) have become an important tool for genomic 
sequencing because of their high stability and large insert size (Shizuya et al., 1992). In addition 
BACs are frequently used for making transgenic organisms due to the fact that in principle all 
regulatory sequences required for natural gene expression can be found in a single BAC (Yang 
et al., 1997). For my thesis, I used BAC recombineering technology in order to make an 
inducible Cdh5 construct as well as a photo-convertible fluorophore-tagged Cdh5 construct. 
Genes in BACs can be modified based on homologous recombination via a technique called 
BAC recombineering (recombination-mediated genetic engineering). BAC recombineering is 
possible in E. coli hosts that harbour a defective λ prophage system. The genome of E. coli that 
are infected with the bacteriophage λ, undergoes recombination based on 50bp homology on a 
highly efficient rate, induced by λ-encoded genetic recombination protein machinery (Poteete, 
2001). However, this λ prophage system does not harm E. coli itself when constitutively 
expressed on a multicopy plasmid (Zagursky and Hays, 1983). The genes encoded on the λ 
prophage system are Exo, which degrades the 5’-ending strand of duplex DNA, RecA, which 
binds to the 5’-ssDNA-overhang generated by Exo, and Bet, which promotes 3’-end 
assimilation in order to anneal complement single-strand DNA (Stahl et al., 1997; Court et al., 
2002). The defective λ prophage system in this study does not contain RecA, but instead a gene 
called Gam, which inhibits another Rec protein (RecBCD) in E. coli thereby protecting linear 
DNA-targeting cassettes from degradation (Figure I-XI). For BAC recombineering purposes, 
E. coli strains are used that contain a stably integrated defective λ prophage system as described 
above, under control of the temperature-sensitive repressor cI857 (Lee et al., 2001).  
 
Figure I-XI. Working mechanism of the defective λ prophage system used for recombineering. 
Exo binds to linear DNA and has a 5′- to 3′-dsDNA exonuclease activity, which generates 3′-overhangs. 
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Subsequently, Beta binds to the 3’overhangs of single-stranded DNA (3′-overhangs), promotes 
annealing of single-stranded DNA and generates recombinant DNA via homologous recombination. 
Gam prevents RecBCD nuclease from degrading double-stranded linear DNA fragments. Adapted from 
Sharan et al., 2009. 
__________________________________________________________________________________ 
 
Another important requirement for efficient genetic editing in BACs is the methods of selection 
for desired modification. I used the SW102 E. coli strain that contains, apart from the heat-
shock inducible defective λ prophage, a galactose operon lacking the gene for galactokinase, 
also called galK (Warming et al., 2005). Because galK is essential for the galactose degradation 
pathway by phosphorylation of galactose, and since phosphorylation of deoxy-galactose (DOG) 
results in an E. coli toxic product, this system can be used for galK-based positive and negative 
selection. To this purpose, SW102 E.coli cells are grown on minimal plates that only contain 
galactose as carbon source. Since this strain is deficient of leucine and biotin metabolism, due 
to the integration location of the λ prophage system, one needs to add both biotin and leucine 
to the minimal plates when selecting (Warming et al., 2005). 
The general BAC recombineering procedure I used, is schematically represented in figure I-
XII. First, a BAC containing the gene that one wants to modify, is transformed into the SW102 
E. coli. One BAC containing bacterium colony is then inoculated to gain a culture of SW102 
that will be prepared for transformation by an electric pulse. Preparation include a heat-shock 
to induce the λ prophage system and washing to get rid of salts. In the first round, the sequence 
coding for galK flanked by homology arms is transformed into the bacterium. The homology 
arms are both identical to the two sequences in the BAC where in between the galK gene should 
be inserted. Only bacteria that have inserted galK by homologous recombination survive on 
minimal plates containing galactose as the only carbon source. One of the surviving colonies is 
subsequently inoculated, prepared for transformation and finally transformed with an insert 
containing the desired modification flanked with the same homology arms as the galK gene 
used in the first round. After the second recombination round, the bacteria are plated on minimal 
plates containing DOG. Only those bacteria that have exchanged their galK gene for the desired 
insert (those who have lost their initially inserted galK) can survive on DOG plates. Surviving 
colonies can finally be tested for having the correct modification (Warming et al., 2005). 
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Figure I-XII. Schematic representation of BAC recombineering procedure. First a BAC containing 
the gene of interest is transformed into SW102. BAC containing SW102 cells are then inoculated and 
transformed with the galK gene (red) flanked by homology arms (yellow). The homology arms are 
identical to the place of the desired modification in the BAC (yellow). Selection for homologous 
recombination of galK takes place in galactose-containing minimal plates (positive selection for galK 
expression). One surviving colony is subsequently inoculated and transformed with in insert containing 
the genetic modification, flanked by the same homology arms as before. Transformed cells are selected 
on DOG containing minimal plates (negative selection for galK expression). Surviving colonies can be 
analysed for desired modification. 
__________________________________________________________________________________ 
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1.5 Transposon-mediated BAC transgenesis in zebrafish and Cre/loxP 
recombination 
 
Microinjection of BACs into fertilised zebrafish eggs leads in 1-3% to integration of the BAC 
into the genome (Yang et al., 2006). Transposon-mediated insertion of genetic material can 
increase integration efficiency substantially. To this purpose, the Tol2 element was identified 
in the genome of the Medaka fish, encoding for a transposase protein, which was found to be 
autonomously active (Kawakami et al., 1998; Kawakami and Shima, 1999). DNA inserts can 
be transposed efficiently via a cut-and-paste mechanism provided that essential cis-sequences 
are present at both ends of Tol2 (Urasaki et al., 2006). In order to use this system for efficient 
BAC integration, these cis-sequences were characterised for minimal length required for Tol2 
activity and were then cloned into a cassette in an outwards directed inversed orientation 
(iTol2). When this iTol2-cassette was subsequently introduced into a BAC and injected together 
with Tol2 transposase, the transposase excised the iTol2 sites and integrated the BAC as a single 
copy into a random single genomic locus (Figure I-XIIIA). In general, 1 to 5 BAC copies were 
found in zebrafish transgenics with insertion lengths up until 66kb (Suster et al., 2009).  
Cre (Causes recombination) is a bacteriophage P1-derived cyclic recombinase that catalyses 
the site-specific recombination between 34bp loxP sites (Locus of crossing over (x) from 
coliphage Pl). A DNA cassette between loxP sites in head-to-head orientation can be inverted 
by Cre-mediated recombination, whereas loxP sites in tandem orientation leads to circulation, 
excision and consequently loss of the cassette between the loxP sites (Figure I-XIIIB) (Sauer, 
1987; Sauer and Henderson, 1988). Since the activity of Cre can be controlled by either 
expression under a heat-shock promoter or activation by tamoxifen (TAM), the Cre-loxP can 
be used for knock-out genes in an inducible way. TAM-inducible Cre is fused to a mutated 
oestrogen receptor, which only becomes activated and then translocates into the nucleus upon 
binding of TAM (Metzger et al., 1995). 
 
 
 
Figure I-XIII. Schematic representation of Tol2-mediated genomic insertion and Cre-loxP 
recombination. (A) When both the insert with inverted tol2 sites and the Tol2 transposon are injected, 
Tol2 cuts the inverted Tol2 (iTol2) sites, resulting in opening of the plasmid and loss of the region 
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between the excisions (green). Subsequently, Tol2 integrates the iTol2-flanked construct into the 
genome (Suster et al., 2009). (B) Active Cre-recombinase can recombine loxP sites. Recombination of 
loxP sites in tandem orientation leads to excision and loss of the construct between the loxP sites (left). 
Recombination of loxP sites in head-to-head orientation leads to inversion of the construct between the 
loxP sites (right) (Renninger et al., 2011).   
__________________________________________________________________________________ 
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1.6 Aim of this thesis 
 
Endothelial cell interactions are key to blood vessel morphogenesis. The endothelial adhesion 
protein Cdh5 is essential for many aspects of this process, including anastomosis and cellular 
rearrangement (cf. 1.2.2. and 1.2.3.). Cdh5 as an anchor for the cytoskeleton is important for 
EC motility and removal of Cdh5 inhibits cellular rearrangement and proper lumen formation 
(Sauteur et al., 2014; Paatero et al., 2018). However, research on Cdh5 dispensability is 
restricted to the fact, that Cdh5-less embryos die around 5dpf. In addition, impaired heart 
development in absence of Cdh5 prevents blood circulation, which hampers phenotypical 
analyses of Cdh5 mutants, because observed phenotypes could be due to the absence of blood 
pressure, rather than the absence of Cdh5 within the endothelial cells under investigation.  
In order to investigate Cdh5-based cell interactions in vivo at different time points during 
embryonic development and to gain mosaic ECs sprouts avoiding the need of transplantation 
experiments, the aim of this thesis is the generation of an inducible Cdh5 knock out zebrafish 
line. To that, I introduce in section 3.1 a system in which mosaic angiogenic sprouts, that 
contain cells with different Cdh5 levels, can be investigated. Via expression of inducible Cre-
recombinase, the expression of cdh5 can be stopped and the behaviour of ECs, which up until 
recombination developed in a wild type environment, can be analysed at any desired 
developmental stage. 
In section 3.2, I introduce a photo-convertible fluorescence tagged Cdh5, using again the same 
BAC recombineering technology. The aim here is generating a tool that can examine to what 
extend individual neighbouring ECs contribute to the formation of JBL dynamics, thereby 
elucidating more about the dynamic endothelial cell behaviours during cell movement. Via 
photo-conversion of single cells, this tool will allow the visualisation of Cdh5 derived from two 
different cells within the same adherens junction by green and red light emission. 
Regulation of the conformation of Cdh5 and the actin cytoskeleton is mainly controlled by 
small GTPases. Since the Rap1 effector Rasip1 was found to control various small GTPases, 
its expression is restricted to ECs and its absence leads to angiogenic phenotypes (Wilson et al., 
2013), the former post-doc Dr. Charles Betz generated a Rasip1 knock out zebrafish line 
(UBS28) and he started with me to characterise Rasip1’s knock out phenotype. Simultaneously, 
I found Radil as a protein whose structure highly resembled that of Rasip1, but which was not 
investigated in the context of angiogenesis so far. When Dr. Charles Betz left the lab, his Rasip1 
project was taken over by the doctoral candidate Minkyoung Lee, whereas I continued mainly 
on characterising the Radil knock-out phenotype and supporting Minkyoung Lee where 
necessary. The first results of this side project are described in section 3.3 and form the basis 
for further comparative analysis with Rasip1 and the Rasip1/Radil double knock phenotype, in 
order to decipher how Rap1 signalling controls angiogenesis.  
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Chapter II 
Materials & Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Methods adapted from Sauteur (2016) are indicated with 1 
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2.1. Materials BAC recombineering 
 
2.1.1. Buffers, media and solutions 
Name Composition 
Biotin 0.2mg/ml d-biotin 
in ddH2O 
sterile filtered 
stored at 4°C up until 4 months 
Deoxy-galactose 20% (w/v) 2-deoxy-galactose 
in ddH2O 
autoclaved 
stored at -20°C 
DNA loading buffer (10x) 30% (v/v) glycerol 
20% (w/v) Orange G 
in ddH2O 
stored at -20°C 
Embryo lysis buffer 10mM Tris pH8 
2mM EDTA 
0.2% Triton-X 
Galactose 20% (w/v) d-galactose 
in ddH2O 
autoclaved 
Gibson master mix 100µl 5x isothermal reaction buffer 
2µl T5 exonuclease  
6.25µl Phusion polymerase 
50µl Taq DNA ligase 
217µl ddH20 
aliquoted into 15μl portions 
stored at -20°C 
Glycerol 20% (w/v) glycerol 
in ddH2O 
autoclaved 
Isothermal reaction buffer 5x (Gibson 
cloning) 
 
0.75g PEG-8000 
1.5ml 1M Tris-HCl, pH 7.5 
150µl 1M MgCl2 
150µl 1M DTT 
30µl 100mM dATP  
30µl 100mM dTTP  
30µl 100mM dCTP  
30µl 100mM dGTP 
300µl 50mM NAD 
ddH20 to 3ml  
aliquoted into 100μl portions 
stored at -20°C 
LB 1% (w/v) tryptone 
0.5% (w/v) yeast extract 
1% (w/v) NaCl 
in ddH2O 
autoclaved 
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Leucin 10mg/ml L-leucin 
in ddH2O 
heated, cooled down and sterile filtered 
Magnesium sulfate 1M MgSO4·7H2O 
M9 Medium 42mM Na2HPO4 
22mM KH2PO4 
18.5mM NH4Cl 
8.5mM NaCl 
in ddH2O 
autoclaved 
M63 Medium (5x) 75.5mM (NH4)2SO4 
500mM KH2PO4 
9μM FeSO4·7H2O 
in ddH2O 
adjusted pH7.0 (with KOH) 
autoclaved 
TAE (50x) 2M Tris Base 
5.71% (v/v) glacial acetic acid 
50mM EDTA 
in ddH2O 
autoclaved 
 
 
2.1.2. Antibiotics 
Antibiotic Stock concentration Working concentration 
Ampicillin 100 mg/ml 100 μg/ml 
Chloramphenicol 34 mg/ml 12.5 μg/ml 
 
 
2.1.3. E. coli bacterial strains 
Name Genotype Source 
Top10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(araleu)7697 galU galK rpsL (StrR) endA1 nupG 
Invitrogen 
SURE e14-(McrA-) Δ(mcrCB-hsdSMR-mrr)171 endA1 gyrA96 thi-1 
supE44 relA1 lac recB recJ sbcC umuC::Tn5 (Kanr) uvrC [F´ 
proAB lacIqZΔM15 Tn10 (Tetr)]. 
Invitrogen 
DH10B F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80dlacZΔM15 ΔlacX74 endA1 
recA1 deoR Δ(ara,leu)7697 araD139 galU galK nupG rpsL λ- 
NEB 
SW102 F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80dlacZ M15 ΔlacX74 deoR 
recA1 endA1 araD139 Δ(ara, leu) 7649 galU galK rspL nupG 
[λcI857 (cro-bioA) <> tet] 
NCI-
Frederick 
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2.1.4. Fish lines 
Name Allele designation Reference 
ABC Wild type (WT) ZIRC, Oregon 
TU Wild type (WT) (Haffter et al., 1996) 
kdrl:EGFP s843 (Jin et al., 2005) 
VE-cadherin 4bp deletion UBS8 (Sauteur et al., 2014) 
kdrl:Cre S898 (Bertrand et al., 2010) 
hs:Cre Zdf13 (Feng et al., 2007) 
 
 
2.1.5. BACs and plasmids 
Name Description Antibiotic Reference 
Cdh5BAC BAC name: CH73-357K2 in 
vector: pTARBAC2 
Chlor-
amphenicol 
BACPAC Resources 
Center 
pGalK E. Coli GalK gene used for 2 
step BAC recombineering 
Ampicillin (Warming et al., 2005) 
p(Itol2;β-
crystellin:mKate2) 
Plasmid containing 2 
inverted Tol2 sites 
(transposon-mediated 
transgenesis) and eye marker 
Ampicillin Gift from Jeroen 
Busmann. Cloned and 
handed over by Etienne 
Schmelzer 
pAttB Intergrase-mediated site-
specific transgenesis 
Ampicillin Gift from Christian 
Mosimann 
p(loxP-Cdh5-
mCherry-loxP-
nls-mCherry) 
cdh5 tagged with marker, 
flanked by LoxP sites 
Ampicillin This study, synthesised 
by ATG:biosynthetics 
GmbH 
pRFP Red fluorescent protein Ampicillin Cloned by Charles Betz 
p(inls-imCherry) Plasmid containing nls-
mCherry in inverted 
orientation 
Ampicillin This study, synthesised 
by ATG:biosynthetics 
GmbH 
pmClavGR2-NT Convertible fluorescent 
protein 
Ampicillin Allele Biotech 
 
 
2.1.6. Oligonucleotides 
Primer name SEQUENCE 
Homo GalK loxp Fo 
CTTATCGATGATAAGCTGTCAAACATGAGAATTGATCC
GGAACCCTTAATCCTGTTGACAATTAATCATCGGCA 
Homo GalK loxp Re 
CCGATGCAAGTGTGTCGCTGTCGACGGTGACCCTATAG
TCGAGGGACCTATCAGCACTGTCCTGCTCCTT 
Tol2_plasmid Fo1 
TCTCCGCACCCGACATAGATCCCTGCTCGAGCCGGGCC
CAAGTG 
Tol2_plasmid Fo2 
GCGTAAGCGGGGCACATTTCATTACCTCTTTCTCCGCA
CCCGACATAGAT 
Tol2_plasmid Rev1 
ATCCTTAATTAAGTCTACTATCAGCCACAGGATCAAGA
GC 
33 
 
Tol2_plasmid Rev2 
GCGGGGCATGACTATTGGCGCGCCGGATCGATCCTTA
ATTAAGTCTACTA 
BAC_tol2LM_foI TACTGCGATGAGTGGCAGG 
BAC_tol2LM_revI GGGTTATTGTCTCATGAGCGG 
BAC_tol2LM_foII GGCCACCTGATCTGCAACTT 
BAC_tol2LM_revII GCACAGCTTGAAGTTGGCTT 
Homo Attb loxp Fo 
CTTATCGATGATAAGCTGTCAAACATGAGAATTGATCC
GGAACCCTTAATGGGTGCCAGGGCGTGCCCTTGGGCTC
CCCGGGCGCGTA 
Homo Attb loxp Re 
CCGATGCAAGTGTGTCGCTGTCGACGGTGACCCTATAG
TCGAGGGACCTATACGCGCCCGGGGAGCCCAAGGGCA
CGCCCTGGCACCC 
Attb_homol_Fo ACGATGAGCGCATTGTTAGA 
Attb_homol_Re CTTATCCACAACATTTTGCGC 
Attb_homol_Seq TCATACACGGTGCCTGAC 
Cdh5_ex3_GalK_fo 
TGATTGCCTTTGTTTATAATTATTTTGTGTGTATTTCTTT
TTTCTTTTAGCCTGTTGACAATTAATCATCGGCA 
Cdh5_ex3_GalK_re 
GAAAGCAACATGCATCAATGGACAAGCACATGCTTGT
GTTAGTCTGTTACTCAGCACTGTCCTGCTCCTT 
BAC_Cdh5_ex3_Del. 
TGATTGCCTTTGTTTATAATTATTTTGTGTGTATTTCTTT
TTTCTTTTAGGTAACAGACTAACACAAGCATGTGCTTG
TCCATTGATGCATGTTGCTTTC 
BAC_ex3_fo AAAAGTATCTTCAAACTATTAAATC  
BAC_ex3_re TCTGTGCCATTTAGTAGTTT 
BAC_ex3_seq GAACTGCTGTTTTTAAATAA 
GalK_exon2_fo 
CTACAAGGCATGAATTATCATACAGATATTTGTTTTGT
TGTTTTCTGCAGCCTGTTGACAATTAATCATCGGCA 
GalK_exon2_re 
CGGATCTCTCCAAATTAAAGTGTGATCCATTTGTTTAC
AAGACCGTCTACTCAGCACTGTCCTGCTCCTT 
Cdh5_exon2_fo AAGTGTATGTACTGTATGG 
Cdh5_exon2_re TATGCTAAGAACCTAAAGAATC 
Cdh5_exon2_seq CTACAAGGCATGAATTATCA 
Homol._tagRFP_Fo 
GGTGAAGAAGGACGAGGCAGATCGTGATCGAGATGCC
GGCGTCTCTAAGGGGGAAGAAC 
tagRFP_homol._Re 
AGCCATAGATGTGTAATGTGTCATAGGGAATGCCGCC
GGCTTTGTACAGTTCATCCATACCA 
Bac_wo_cherry_fo GCCGGCGGCATTCCCTATG 
Bac_wo_cherry_re GCCGGCATCTCGATCACGATC 
Homol_UTR_fo 
TTATGGAGTAGACGGCTCTGATTCGGATAGCTCCTACT
GAAGTCCATGGTCATCATC 
UTR_homol_Re 
TATAATGTATGCTATACGAAGTTATTAAGATACATTGA
TGATAGTGAGTTAATAATCATCTGATT 
Bac_wo_polyA_Fo CATCAATGTATCTTAATAACTTCG 
Bac_wo_polyA_Re TCAGTAGGAGCTATCCGAAT 
RFP_pl2_fo GGTGAAGAAGGACGAGGC 
RFP_pl2_Re AGCCATAGATGTGTAATGTGTCATA 
Plasmid1_fo_RFP ATCTCGATCACGATCTGCCT 
Plasmid1_re_RFP GGCATTCCCTATGACACATTACA 
Galk_mClav_fo 
TGGCCATGATGATCGAGGTGAAGAAGGACGAGGCAGA
TCGTGATCGAGATCCTGTTGACAATTAATCATCGGCA 
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Galk_mClav_re 
GATTCGGTTCCCTCATAGCCATAGATGTGTAATGTGTC
ATAGGGAATGCCTCAGCACTGTCCTGCTCCTT 
Homo_mClav_fo 
TGGCCATGATGATCGAGGTGAAGAAGGACGAGGCAGA
TCGTGATCGAGATGCCGGCGTGAGCAAGGGCGAGGAG 
Homo_mClav_re 
GATTCGGTTCCCTCATAGCCATAGATGTGTAATGTGTC
ATAGGGAATGCCGCCGGCCTTGTACAGCTCGTCCATGC
C 
Pcr_mClav_fo GACCTGCACTTTATGCCATGG 
Pcr_mClav_Re GGTTAGACCCACTGGACGA 
Pcr_mClav_Seq TGGCCATGATGATCGAGGTG 
cDNA_oligo_dT TTTTTTTTTTTTTTTTTT 
cDNA_mCherry_Re CTTGTACAGCTCGTCCATGC 
cDNA_RFP_Re ATGTCCCAGTTTACTCGGCA 
cDNA_PCR_Fo_I CAGGGAAAACGACTGTTGAA 
cDNA_PCR_Fo_II ATGGAGTAGACGGCTCTG 
cDNA_PCR_Re TTGATGTTGACGTTGTAGGC 
cDNA_PCR_RFP_Fo TGCGTATCAAGGTCGTCG 
cDNA_PCR_RFP_Re  TTGTCAGCCTCCTTGATTCTC 
cDNA_PCR_ORF_Fo TATTTTTAACCAAACAGAGTACACGT 
cDNA_PCR_ORF_Re AACCTCCTTGCTTCAGC 
GalK_invt._Fo 
TGGCTCAGCTTTATGGAGTAGACGGCTCTGATTCGGAT
AGCTCCTACTGACCTGTTGACAATTAATCATCGGCA 
GalK_invt._Re 
CGGATCTCTCCAAATTAAAGTGTGATCCATTTGTTTAC
AAGACCGTCTACTCAGCACTGTCCTGCTCCTT 
Invt._constr._Fo 
TGGCTCAGCTTTATGGAGTAGACGGCTCTGATTCGGAT
AGCTCCTACTGAGATCTTTTTCCCTCTGC 
Invt._constr._Re 
CGGATCTCTCCAAATTAAAGTGTGATCCATTTGTTTAC
AAGACCGTCTACATAACTTCGTATAGCATACATTATA 
PCR_Invt_Fo TAACCTGGATTATGATTTTATACAT 
PCR_Invt_Re ACAGCAAATGTAATGTTGT 
PCR_Invt_Seq TGGCTCAGCTTTATGGAGTA 
Backbone – ORF_Fo GTGTGAACGCAGCATTATG 
Backbone – ORF_Re AAGGACAACAATATCCCCATT 
LoxP-I & ORF-I_Fo TTTTATATTTGACATATGTCTGT 
LoxP-I & ORF-I_Re AGCAGGTTAACACTCTT 
LoxP-I & ORF-I_seq1 CATCATTGTTTTATGTTATT 
LoxP-I & ORF-I_seq2 TGCTGTTCAAGCCAAAGACA 
ORF-II&RFP-PolyA_Fo AGGTTTCAGTACAGAGAATTC 
ORF-II&RFP-PolyA_Re CAGGCGGAATGGAC 
ORF-II&RFP-PolyA_sq1 CTGATGGAGGAACGCCAGAG 
ORF-II&RFP-PolyA_sq2 GCTTGGCTGGGAGGCCAACA 
nlsmCherry_inv_Fo GTAAAACCTCTACAAATGTGGTA 
nlsmCherry_inv_Re GTCTGTGGAAGAAATCACA 
nlsmCherry_inv_Seq TTATGATCAGTTATCTAGAT 
cDNAsynth_Cherry CTTGTACAGCTCGTCCATGC 
cDNAsynth_RFP ATGTCCCAGTTTACTCGGCA 
cDNAsynth_Gen. TTTTTTTTTTTTTTTTTT 
cDNA_PCR_ORF_fo TATTTTTAACCAAACAGAGTACACGT 
cDNA_PCR_ORF_re AACCTCCTTGCTTCAGC 
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cDNA_PCR_RFP_fo ATGCGTATCAAGGTCGTCG 
cDNA_PCR_RFP_re TTGTCAGCCTCCTTGATTCTC 
cDNA_PCR_foI CAGGGAAAACGACTGTTGAA 
cDNA_PCR_fo2 ATGGAGTAGACGGCTCTG 
cDNA_PCR_re TTGATGTTGACGTTGTAGGC 
 
 
2.1.7. Microscopes and binoculars 
Instrument Manufacturer Information Objectives 
SP5 Matrix Leica Confocal microscope, 
PMT, HyD 
10x air; NA=0.3 
40x water; NA=1.1 
SP8 Bsl2 Leica Confocal microscope, 
PMT, HyD 
10x air; NA=0.3 
40x water; NA=1.1 
Leica M205 FA Leica Fluorescence binocular  
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2.2. Methods BAC recombineering 
 
Paragraphs 2.2.1., 2.2.2., 2.2.3. and 2.2.4. are based on and optimised from (Warming et al., 
2005), protocol 3. 
 
2.2.1. Generation of insert probes 
For each modification a set of two probes to be inserted into the BAC, needs to be designed and 
synthesised. First, two primers around the galK gene, flanked at the 5’ ends by 50bp-long 
homology arms, were generated. These homology arms corresponded exactly to the 50bp 
regions at both sides of the desired position in the BAC to be modified. In that case, the primers 
looked as follows: 
Forward: 5’------------50bp_homology-------CCTGTTGACAATTAATCATCGGCA-3’ 
Reverse: 5’----50bp_homology_compl._strand----TCAGCACTGTCCTGCTCCTT-3’ 
The first probe containing the galK gene was synthesised by PCR using the homology arm 
containing primers as described above, yielding a PCR product of 1331bp. The PCR reaction 
was set up as described below: 
Component Final Concentration 
5x Q5 Reaction buffer 1x 
dNTPs 200μM 
Forward primer with homology arm 0.5μM 
Reverse primer with homology arm 0.5μM 
GalK plasmid 1 ng 
Q5 Polymerase 0.02U/μl 
H2O  to 25μl 
 
Thermal cycling reaction Temperature Duration  
Initial denaturation 98°C 30sec  
Denaturation 98°C 10sec  
30 cycles Annealing 60°C 30sec 
Extension 72°C 30sec 
Final extension 72°C 2min  
 
Secondly, two primers around the sequence desired to be inserted at the site of modification 
were synthesised. In order to substitute the initially inserted galK (cf. 2.2.3) in the BAC, this 
second pair of primers should contain the exact same homology arms as the galK PCR primers. 
The PCR procedure is similar as above, in which the annealing temperature should be adapted 
to the DNA template binding part of the primers (NEB TM calculator is a reliable tool to this). 
The duration of the annealing phase needs to be prolonged in case the DNA template exceeds 
1000bp (count 30sec per 1000bp). 
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At the end of the PCR reaction, 1μl DpnI was directly added to the reaction mix and kept on 
37°C for 30min. This step is key to remove any plasmid templates (methylated) from the PCR 
products (not methylated) in order to avoid false positives during transformation. Finally, a 
PCR column clean-up (NucleoSpin® Gel and PCR Clean-up) suffices to purify both PCR 
products.  
 
2.2.2. Agar minimal plates preparation 
In order to obtain 20 (deoxy-)galactose-containing agar plates, 7.5g agar in 400ml H2O was 
autoclaved in a 1L flask. Subsequently, 100ml 5x M63 medium and 500μl 1M MgSO4·7H2O 
were added. After cooling down to 50°C, the following products were added: 
Component Quantity 
Carbon source 
(either A. galactose or B. deoxy-galactose and glycerol)  
5ml 
Biotin 2.5ml 
Leucine 2.25ml 
Chloramphenicol 188μl (12.5 μg/ml) 
 
For 20 MacConkey plates, 25g MacConkey agar (Sigma-Aldrich) in 400ml H2O was 
autoclaved in a 1L flask. After cooling down to 50°C, the following products were added: 
Component Quantity 
Galactose 5ml 
Chloramphenicol 188μl (12.5 μg/ml) 
 
The above agar compositions were then poured into petri dishes whereupon the remaining air 
bubbles were eliminated with a crème brûlée gas burner. These plates can be stored at 4°C up 
until one month. Per single modification in the BAC, at least six minimal plates containing 
galactose, six containing deoxy-galactose and three MacConkey plates are needed.  
 
2.2.3. BAC recombineering procedure 
BAC recombineering is a technique that allows site-specific modifications (sequence insertions, 
point mutations, removal of sequences) of the sequence within a BAC based on homologous 
recombination. BAC recombineering is performed using a special bacterial strain, called 
SW102 E. coli, which expresses λ-prophage genes under control of a temperature-sensitive 
repressor that encode for homology recombination-facilitating proteins (cf. section 1.4). In 
addition, its galactose operon lacks the galK gene, which allows selecting recombinants on the 
introduction of galK in a first step on growing plates containing only galactose as a carbon 
source. Moreover, it allows selection against the presence of galK in a second recombineering 
step based on survival on minimal growing plates containing deoxy-galactose. My protocol 
works best as follows: 
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a. Introduction of the BAC into SW102 
 
1) When using a BAC for the first time, it first needs to be transformed into SW102 E. coli. 
After purification of the BAC using NucleoBond® BAC 100 (Macherey-Nagel), 30ng 
BAC was transformed into electro-competent SW102 E. coli., recovered for 1 h at 32°C 
in standard LB and plated on LB agar plates with 12.5μg/ml chloramphenicol at 32°C. 
 
 
b. Preparation of a BAC containing SW102 culture 
 
2) BACs that are hosted by SW102 E. coli were inoculated into 5ml standard LB with 
chloramphenicol at 32°C overnight, the evening prior to recombineering. 
 
3) Next morning, 500µl of the overnight culture was diluted into 25ml standard LB with 
chloramphenicol in a 200ml Erlenmeyer flask and placed in a shaking incubator at 32°C. 
The culture was grown until an OD600 of approximately 0.6, which usually took 3 h. 
 
 
c. Heat shock of SW102  
 
4) From the moment the bacteria have reached their exponential growth phase (OD 0.6), 
the water bath was set at 42°C. Meanwhile 12ml of the culture was transferred to a new 
200ml Erlenmeyer flask, which was then placed into 42°C-heated water for exactly 
15min. The remaining culture was kept at 32°C as an “un-induced” control. 
 
5) Meanwhile, the centrifuge was switched on to reach a temperature of at most 4°C and a 
bucket was filled with ice floating in water, forming an ice-water slurry. A 50ml tube 
filled with ddH2O was placed into the ice-cold water. 
 
 
d. Preparation of salt-free SW102 culture 
 
6) After 15 minutes, both the induced and un-induced samples were briefly cooled in the 
ice-water slurry and transferred into 10ml tubes with convex bottom. Subsequently, the 
two cultures were pelleted in the pre-cooled centrifuge at 0°C, for 5min using 4200rpm. 
 
7) During the next step, the supernatant was discarded and the pellet was re-suspended in 
1ml ice-cold ddH2O, by gently swirling the tubes in the ice-water slurry. The culture 
should not be pipetted, since shear stress would damage the BAC DNA. One should 
preferably use tubes with convex bottom; otherwise re-suspending the cells will take 
ages. Finally, another 9ml ice-cold ddH2O was added to each tube and pelleted again as 
in step 6. 
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8) Step 7 was repeated two times, but after the second washing step, the re-suspended 
culture was transferred to a 15ml tube with pointed bottom. This allowed an easier 
harvest of the cells in the next step.  
 
9) After pelleting the now washed and salt-free cultures, the complete supernatant was 
removed by inverting the tubes on a paper towel. The pellet was then suspended in 50µl 
ddH2O by pipetting very gently and was kept on ice until electroporation. 
 
 
e. Electro-transformation of galK 
 
10) 25µl Of each culture ware then transferred into three 1.5ml tubes: induced, un-induced 
and no insert control. To the induced and un-induced cells, 50-100ng homology arms 
containing galK PCR product (cf. section 2.2.1.) was added. The content of each tube 
was transferred to a 0.1cm cuvette (BioRad) and transformed by an electric pulse: 25µF, 
1.75kV and 200Ω. In case the cultures explodes during electroporation, I advise to add 
an extra washing step next time and/or suspend the pelleted samples in 100µl. 
 
11) Directly after electroporation, the cells were recovered into 1ml standard LB without 
antibiotics for 1h at 32°C in a shaking heat block (750rpm). This step allowed the cells 
to recover and express their antibiotic resistance genes. 
 
 
f. Preparation of a transformed SW102 cells for selection 
 
12) After the recovery period, the three samples were pelleted in a table top centrifuge 
(11,000rpm, 30sec) and their supernatant was removed. Subsequently, the cells were re-
suspended in 1ml M9 medium, in order to remove all nutrition present in LB, but 
thereby supplying essential salts. Again, pipetting was done in a cautious way. 
 
13) Washing in M9 medium as in step 12 was repeated once more. After the second washing 
round, the pellet was re-suspended in 1ml M9 medium. These now LB-free samples 
were serially diluted 1:10 and 1:100 (100µl into 1ml M9 medium, from which one 
dilutes 100µl in 1ml M9 medium).  
 
 
g. Plating and selection of cells 
 
14) 100µl Of the 1:10 and 1:100 dilutions of the induced, un-induced and no product control 
samples were then plated on minimal plates that only contain galactose as unique carbon 
source (cf. 2.2.2.). The plates were subsequently incubated at 32°C for 3 days. 
 
15) When they started to become visible, a few single colonies from the induced 
transformed samples were picked (check controls which dilution series worked best) 
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and streaked on MacConkey plates with galactose and chloramphenicol. GalK will 
ferment lactose, thereby lowering the pH, which converts the neutral red dye present in 
MacConkey into pink colour. This step allowed finding pure colonies, deriving from 
one single cell containing the galK gene. An overnight incubation at 32°C sufficed. 
 
 
h. Preparation of a galK containing SW102 culture for electroporation 
 
16) The next day, a single bright pink colony was incubated overnight in 5ml LB with 
chloramphenicol at 32°C. 
 
17) Steps 3 to 10 were repeated in order to obtain electro-competent SW102 cells. However, 
instead of transforming a Galk PCR product, the PCR product containing identical 
homology arms and the desired insert/modification was now used. 
 
18) After the transformation, the cells were recovered in 200ml Erlenmeyer flasks 
containing 10ml standard LB without antibiotics at 32°C in a shaking incubator 
(150rpm). To get best chances to obtain pure BAC (by this dilution) that have lost their 
galK present during the recombination, the samples were recovered for at least 4 h. 
 
 
i. Selection against galK 
 
19) The transformed cells were then washed twice in M9 medium and plated on deoxy-
galactose containing minimal plates identical to steps 12 to 14. 
 
20) Three days later, when the colonies became visible, a dozen of single colonies were 
picked and incubated overnight in 5ml LB with cloramphenicol. Next day, minipreps 
(cf. 2.2.4.) were made and tested by PCR (cf. 2.2.8.) whether the desired modification 
had taken place. 
 
 
2.2.4. BAC minipreps 
For BAC minipreps (1-1.5mg), 5ml overnight LB culture with chloramphenicol was pelleted 
for 5min at 4,200rpm, the supernatant removed, and the pellet dissolved in 250ml buffer P1 
(miniprep kit, Qiagen) and transferred to an Eppendorf tube. 250ml P2 buffer was added, 
followed by mixing by inversion and incubation for <5min at room temperature. Then 250ml 
of N3 buffer was added, followed by mixing and incubation on ice for 5min. The supernatant 
was cleared by two rounds of centrifugation at 13,200rpm for 5min in a table top centrifuge. 
Each time the supernatant was transferred to a new tube. DNA was precipitated by adding 
750ml isopropanol, followed by mixing and incubating on ice for 10min, and centrifugation for 
10min at 13,200rpm. The pellet was then air-dried for 10min and dissolved 50ml ddH2O.  
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Making minipreps of recombineered BACs allowed to quickly purify BACs good enough to 
screen for correct recombinants by PCR. Sequencing of the PCR products was performed at 
Microsynth using barcode labelled tubes. Reactions mixtures were assembled as indicated on 
the company’s website (www.microsynth.ch). Based on its outcome, one colony can be chosen 
and inoculated for purification by the much more laborious, nevertheless highly accurate 
midiprep procedure of NucleoBond® BAC 100 (Macherey-Nagel).  
Only purified BACs by midiprep can be used for restriction enzyme analyses (cf. 2.2.5.) and 
injections into zebrafish zygotes (cf. 2.2.7.). Freshly purified BACs can be stored at 4°C for 
maximal 1 month. In order to store the BAC over long time, one should re-suspend a 5ml 
overnight culture in 20% glycerol solution, which can be maintained for years at -80°C. 
 
2.2.5. Restriction enzyme digestion 
For BAC analysis by restriction digest, 3µg of BAC midiprep was added to a restriction digest 
reaction containing 15µl Cutsmart buffer (NEB), 3µl restriction enzyme, filled up to 150µl 
ddH2O. After a 1-hour incubation at 37°C, 500µl ethanol was added to the reaction mix and 
centrifuged for 20min at 4°C using 20.000rpm. Subsequently, the supernatant was removed, 
the pellet air-dried for 10min and resolved in 20µl ddH2O. The cut products were separated in 
ethidium bromide containing gels by electrophoresis and visualised under UV light. 
 
2.2.6. Tol2 transposase in vitro mRNA transcription1 
Generally, mRNA was transcribed with Ambion kits. 1μg of NotI-linearised pCS2FA-
transposase plasmid was used to transcribe mRNA with mMESSAGE mMACHINE® SP6 
Transcription Kit (Ambion) according to the manufacture’s protocol. The LiCl precipitated 
RNA was resuspended to 200ng/μl, aliquoted and stored at -80°C until usage. 
 
2.2.7. BAC injections1 
The injection mix consisted of: 
Component Quantity 
Fresh BAC purified using NucleoBond® BAC 100  25ng/μl 
Tol2 protein 20ng/μl 
Phenol Red 10x 1:10 
ddH2O fill up to 10μl 
 
Borosilicate glass needles for injections were produced from capillaries (outer diameter 1.0mm, 
inner diameter 0.5mm, 10cm length; Sutter Instruments) with a needle puller (Sutter 
Instruments). Freshly laid eggs were mounted into the grooves of moulded agarose (1% in 1x 
E3) in petri dishes and covered with egg water. Glass needles were loaded with injection 
mixture using Micro loader tips (Eppendorf), broken at the tip with forceps and finally the 
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needle was connected to a pneumatic Pico Pump (SYS-PV820) from WPI. The constant 
pressure was set to minimum and the injection pressure was adjusted (visually, whilst injecting) 
to a volume of approximately 5nl. The single cell (one-cell stage) of the freshly laid eggs was 
then injected. 
 
2.2.8. DNA extraction and PCR analysis 
In order to check whether the BAC has completely integrated in the genome, injected embryos 
with red eye marker were put in 50μl embryo lysis buffer, to which 0.5μg/ml proteinase K was 
added. After an overnight incubation at 55°C, proteinase K was inactivated by cooking at 95°C 
for 10min. The samples were cooled down, briefly vortexed, whereupon 2μl was used as DNA 
template. PCR was executed using primers listed in section 2.1.5. as follows: 
Component Final Concentration 
5x Q5 Reaction buffer 1x 
dNTPs 200μM 
Forward primer 0.5μM 
Reverse primer  0.5μM 
2μl DNA template from DNA extraction mix - 
Q5 Polymerase 0.02U/μl 
ddH2O  to 25μl 
 
Thermal cycling reaction Temperature Duration  
Initial denaturation 98°C 30sec  
Denaturation 98°C 10sec  
30 cycles Annealing depending on primers 30sec 
Extension 72°C 30sec 
Final extension 72°C 2min  
 
 
2.2.9. Imaging procedure1 
BAC injected embryos were selected under the fluorescent binocular for presence of the red 
eye marker. Before mounting, embryos were anesthetised in 1x E3 containing 1x tricaine. 0.7% 
Low Melting Agarose (LMA) (Sigma) was dissolved in 1x E3. Before usage, the LMA was 
melted in the microwave and supplemented with 1x tricaine. The LMA mixture was kept at 
50°C during mounting. A glass bottom dish (MatTek) was coved with LMA and allowed to 
cool down a bit. Life embryos were dropped with a fish pipette into the agarose drop and 
orientated with an eyelash-containing handle. The samples were then imaged at the SP5 Matrix 
confocal microscope, with either 20x or 40x magnification. 
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2.2.10. Preparation and transformation of electro-competent E. coli cells1 
A fresh Top10 E.coli colony was picked to inoculate LB without salt and grown overnight at 
37°C with 200rpm. The following morning, the culture was diluted 1:100 in LB without salt 
(without antibiotics), grown to OD600 = 0.6-0.8 and cooled down in an ice slurry. Bacteria 
were pelleted in a precooled centrifuge, washed once in 10% glycerol (sterile and ice cold) and 
re-suspended in 10% glycerol in a 100th of the initial volume. Bacterial suspension was 
aliquoted and used immediately or frozen in liquid nitrogen for storage at -80°C. 
For transformation electro-competent cells were thawed on ice mixed with construct (20-
100ng) or plasmid (<500pg) into a Gene Pulser/Micro Pulser 1mm Cuvette(Bio-Rad) and 
electroporated at 1.8kV with a Micro Pulser (Bio-Rad).Subsequently the cells were re-
suspended in LB (without antibiotics) and incubated for 1h at 37°C. Dilutions of cells were 
plated on standard agar plates with appropriate antibiotics. 
 
2.2.11. Gibson cloning procedure 
The Gibson cloning method used here is based on Gibson et al., 2009: 
 
Gibson cloning allows multiple DNA fragments with overlapping homology arms to be 
assembled into a circular plasmid in a single-tube reaction.  Pieces of DNA, either linearized 
plasmids or PCR products, were designed with 40bp overlaps. 
First, equimolar amounts of gel-purified DNA were added together, 10-100ng per piece with a 
total volume of 5µl. If DNA is amplified from a plasmid, a DpnI digest on the PCR reaction 
should be performed. Then a 15µl aliquot of 1.33x Gibson Master Mix was thawed on ice, 
whereupon 5µl DNA was added to the tube and incubated at 50°C for 1h. Then, 3µl of the 
reaction was transformed into electric-competent Top10 E.coli cells.  After transformation, the 
cells are recovered in LB for 1h and streaked on agar plates with appropriate antibiotic. Next, 
day the growing colonies can be inoculated for plasmid purification via a miniprep 
(NucleoSpin® Plasmid). Purified plasmids were screened by PCR and sequencing.  
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2.2.12. cDNA synthesis from BAC-injected embryos 
In order to purify enough mRNA from BAC-injected embryos, twenty embryos were pooled in 
two tubes for 1. expressing red eyes and 2. not expressing red eyes. RNA was subsequently 
purified following the protocol of Qiagen®’s RNeasy Minikit. cDNA was synthesised using 
Invitrogen™ SuperScript III Reverse Transcriptase and analysed by PCR. 
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2.3. Materials to characterisation of RadilB and Rasip1 
 
2.3.1. Buffers, media and solutions as far as not mentioned in 2.1.1. 
Name Composition 
Alkaline Tris buffer 100mM Tris-HCl pH9.5 
50mM MgCl2 
100mM NaCl 
0.1% Tween-20 
BCIP solution (in situ) 50mg 5-bromo-4-chloro-3-indolyl phosphate (BCIP, Sigma) 
in N,N-dimethylformamide (anhydrous) 
stored at -20°C  
in the dark 
Blocking solution 5% normal goat serum 
1% BSA 
0.1% Triton X-100 
0.01% sodium azide 
in PBST 
Blocking solution (in 
situ) 
2% sheep serum 
2mg/ml BSA 
0.01% sodium azide 
1x PBST 
E3 (50x) 250mM NaCl 
8.5mM KCl 
16.5mM CaCl2 
16.5mM MgSO4 
adjusted pH7.0-7.4 (with Na2CO3) 
Hybridisation Mix (in 
situ) 
5x SSC 
50% deionized Formamide 
50μg/ml Heparin 
500μg/ml torula RNA (Sigma) 
adjust to pH6 (460μl 1M citric acid per 50ml solution) 
stored at -20°C 
Labeling solution (in 
situ) 
225μl NBT solution 
50ml Alkaline Tris Buffer 
175μl BCIP solution 
Methylene blue 
solution 
1% Methylene Blue (Sigma) 
ddH2O 
NBT solution (in situ) 50mg Nitro Blue Tetrazolium (NBT, Sigma) 
70% N,N-dimethylformamide 
ddH2O 
stored at -20°C in the dark 
PBS (10x) 1.37M NaCl 
27mM KCl 
100mM Na2HPO4 
18mM KH2PO4 
ddH2O 
autoclaved 
PBST 1x PBS 
0.1% Tween-20 
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PFA (4%) heat 500ml 1xPBS pH7.2 to 60°C (under the hood) 
add 40g Paraformaldehyde 
add 2N NaOH drop by drop until PFA dissolved 
cool down, adjust volume to 1l with 1x PBS 
filtrate 
stored at -20°C 
PTU (50x; 2mM) 0.15% (w/v) 1-Phenyl-2-thiourea (PTU) (Sigma- 
Aldrich) 
in egg water 
Stop solution (in situ) 1x PBS pH5.5 
1mM EDTA 
0.1% Tween-20 
Tricaine (25x) 0.4% (w/v) Tricaine (Sigma) 
ddH2O 
adjust pH7.0 with 1M Tris HCl 
stored at -20°C 
 
2.3.2. Fish lines 
Name Allele designation Reference 
ABC/TU Wild type (WT) ZIRC/(Haffter et al., 1996) 
kdrl:EGFP s843 (Jin et al., 2005) 
kdrl:EGFPnls UBS1 (Blum et al., 2008) 
Gata1:dsRed sd2 (Yaqoob et al., 2009) 
Tension-sensor Tg(ve-cad:ve-cadTS) (Lagendijk et al., 2017) 
RadilB mutant sa20161 This study 
Rasip1 mutant UBS28 This study, generated by Charles 
Betz, maintained by Minkyoung Lee 
 
2.3.3. Oligonucleotides 
Primer name Sequence 
RadilB_mut_Fo1b CCACAACAACCGGCTAACCAC 
RadilB_mut_Re1b ACAATGAGCCTGGGTTGCAAATAA 
RadilB_mut_Re2c TGGCCAGCACACTCTTTT 
RadilB_mut_Fo2b GCCAGGGGACCAACTATA  
 
2.3.4. Antibodies 
Primary antibody Host Dilution Reference 
Rasip1 Rabbit 1:500 (Wilson et al., 2013) 
Cdh5 Guinea Pig 1:500 (Blum et al., 2008) 
RadilB Rabbit 1:100-500 This study 
 
Secondary antibody Host Dilution Source 
Anti-Rabbit Alexa 633 Goat 1:500 Abcam 
Anti-guinea pig Alexa 568 Goat 1:500 Abcam 
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2.4. Methods to characterisation of RadilB and Rasip1 
 
2.4.1. Fish maintenance 
Zebrafish were raised and maintained at standard conditions as described in “The Zebrafish 
Book” (Westerfield, 2000). Embryos were staged at 28.5°C (Kimmel et al., 1995). 
 
2.4.2. Genotyping of RadilB mutant 
Adult zebrafish were anesthetised in 1x E3 containing 1x tricaine. Paralysed fish were placed 
on a sterile surface and the caudal fin was spread. A razor blade was pressed vertically onto the 
distal part of the caudal fin and a pipette tip was used to slide along the razor blade, cutting off 
the fin. The DNA of the tissue sample was extracted by alkaline lysis (200μl of 50mM NaOH, 
20min at 95°C. Then chilled on ice and addition of 20μl 1M Tris-HCl. Finally centrifuged at 
11.000rpm for 5min. Fin clipped fish were kept individually in single cages containing egg 
water until genotypes were determined by PCR using the four primers of paragraph 2.3.3.: 
 
Component Final Concentration 
10x Titanium Taq PCR buffer 1x 
dNTPs 10mM 
RadilB_mut_Fo1b 10μM 
RadilB_mut_Re1b 10μM 
RadilB_mut_Re2c 10μM 
RadilB_mut_Fo2b 10μM 
1μl DNA template from DNA extraction mix - 
Q5 Polymerase 20ng/μl 
ddH2O  to 25μl 
 
Thermal cycling reaction Temperature Duration  
Initial denaturation 95°C 1min  
Denaturation 95°C 30sec  
28 cycles Annealing 61°C 30sec 
Final extension 68°C 3min  
Depending on the genotype, this PCR procedure can produce three different bands: 570bp 
(outer/control band), 400bp (wt band) and 200bp (mut band). 
 
2.4.3. Immunohistochemistry 
Embryos were transferred in 1,5ml Eppendorf tubes and fixed in 2% PFA in PBST overnight 
at 4°C. Next day, the samples were washed 4 times, roughly 30min each, in 1ml PBST at room 
temperature. Then blocking solution was added for around 4h at room temperature. At the end 
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of the day, the embryos were incubated in 500µl primary antibodies in blocking solution, 
overnight at 4°C. On the second day, the embryos were washed six times, 1h each, in 1ml PBST 
at room temperature. At the end of the day, the embryos were incubated in 500µl secondary 
antibodies in blocking solution, overnight at 4°C, kept in the dark by aluminium foil. On the 
third day, the embryos were washed five times, 1h each, in 1ml PBST at room temperature. The 
last washing step took place overnight at 4°C before imaging. Imaging was performed as 
described in 2.4.5. 
 
2.4.4. In situ hybridisation1 
In situ hybridisation is a technique to visualise the presence of specific mRNA by hybridising 
a target mRNA with a labelled antisense probe. This allows identifying the expression 
localisation of specific genes within fixed tissues and cells. 
In this study, exon 5 of RadilA, RadilB and RadilC respectively were amplified by PCR, 
followed by A-tailing with Taq polymerase. Subsequently these probes were cloned into p-Gem 
t-easy vectors. The in situ hybridisation protocol was adapted from (Thisse and Thisse, 2014). 
DIG-labelled RNA was transcribed from linearized Radil exon 5 containing p-Gem t-easy 
vectors with SP6 RNA polymerase and ingredients for 2h at 37°C: 
 
Reaction mix DIG-labeled RNA synthesis 
1μg linearized plasmid 
1x DIG RNA labeling mix (Roche) 
1x Transcription buffer (Roche) 
40U RNA polymerase (Roche) 
20U RNase inhibitor (Roche) 
Up to 20μl Nuclease Free H2O (Ambion) 
Template DNA was then degraded by incubation with 2U TURBO DNase I (Ambion) for 
15min at 37°C, and the RNA was precipitated using LiCl (protocol and reagents of Ambion 
mMessage mMachine transcription kits). Pre- and post-precipitation RNA were checked on 
Ethidium Bromide gel. RNA was frozen at -80°C until use. 
Eggs were then collected right after they were laid and raised to the desired developmental stage 
(e.g. 30hpf), while the formation of pigments was prevented by adding PTU to the egg water. 
The chorions were manually removed before fixation in 4% PFA (o/n) at 4°C. The embryos 
were dehydrated by incubation in 100% methanol for 15min. at RT, during this process the 
methanol was exchanged once. Thereafter, the embryos (in methanol) were incubated at -20°C 
for more than 2h. The embryos were successively rehydrated in methanol dilutions (75% / 50% 
/ 25% (v/v) Methanol and PBST, each step for 5min) and finally washed 4 times for 5min in 
PBST. Then, the embryos were permeabilised with Proteinase K (Roche) (10μg/ml in PBST) 
at RT. Depending on their developmental stage, the incubation with Proteinase K was 
prolonged (e.g. embryos at 28hpf for 15min, or 36hpf for 20min). Proteinase K was inhibited 
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by fixation of the embryos in 4% PFA for 20min at RT and subsequently washed 4 times for 
5min in PBST. 
The embryos (less than 100) were prehybridised in 700μl hybridisation mix for 5h. at 67°C. 
Then the hybridisation mix was replaced with 200μl fresh one, containing 50ng DIG-labeled 
RNA probe and 5% Dextran Sulfate (Merck Millipore) and the incubation was continued 
overnight at 67°C. The next day, the buffer was successively exchanged to 0.2x SSC. Therefore, 
the embryos were incubated in each of the following pre-warmed (67°C) mixes for 10 min: 
100% Hybridisation mix (w/o RNA and heparin), 75% / 50% / 25% (v/v). Hybridisation mix 
in 2x SSC, and 2x SSC. Finally the embryos were washed twice 30min in pre-warmed 0.2x 
SSC at 67°C. Thereafter, the SSC was progressively replaced with PBST by incubating the 
embryos at RT in 75% / 50% / 25% (v/v) 0.2x SSC in PBST and finally 100% PBST 10min for 
each step. 
After the buffer exchange to PBST, the embryos were blocked for 3-4h at RT in Blocking 
solution (in situ) and the AP-anti-DIG antibody (Roche) was applied onto the samples, diluted 
1:5000 in Blocking solution (in situ). After overnight incubation at 4°C, the antibody was 
washed away by 6 times 15min PBST incubations. To prevent the formation of precipitates the 
samples were washed once in alkaline Tris buffer devoid of MgCl2 and subsequently incubated 
twice for 5min in normal alkaline Tris buffer. To start the colorimetric reaction, the embryos 
were incubated at 37°C in freshly made labelling solution and monitored. The incubation time 
is around 4-5h. at 37°C. Finally, the labelling reaction was stopped by washing twice in stop 
solution (in situ). The embryos were kept in stop solution at 4°C in the dark until usage or 
placed in 100% Glycerol (Sigma-Aldrich) overnight at room temperature to be imaged the next 
day. 
 
2.4.5. Imaging procedure1 
Before mounting, embryos were anesthetised (not for fixed samples) in 1x E3 containing 1x 
tricaine and selected on a fluorescent binocular. 0.7% Low Melting Agarose (LMA) (Sigma) 
was dissolved in 1x E3. Before usage, the LMA was melted in the microwave and supplemented 
with 1x tricaine (not necessary for fixed samples). The LMA mixture was kept at 50°C during 
mounting. A glass bottom dish (MatTek) was coved with LMA and allowed to cool down a bit. 
Life embryos or tail of fixed specimen were dropped with a fish pipette into the agarose drop 
and orientated with an eyelash-containing handle. 
The samples were then imaged at the SP5 Matrix confocal microscope, with either 20x or 40x 
magnification. Generally, laser intensities and detector intensities or exposure times were set to 
obtain single saturated pixels. For recording 3D images (stacks of focal planes) the step size in 
z-directions was set from 0.1μm to 1μm for objectives with magnification higher than 20x, for 
objectives with magnification with 10x or 20x the section thickness was set to 1μm to 4μm. For 
short and overnight time lapse recordings the incubation chamber of the confocal microscope 
was set to 28.5°C. When recording single images of live or fixed sample, the imaging was done 
at RT. 
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3.1. Generation of an inducible Cdh5 line 
 
The desire to examine the function of Cdh5 at different developmental stages of angiogenesis 
in zebrafish and to analyse EC behaviour in mosaic angiogenic sprouts with different Cdh5 
levels, let to the idea to generate an inducible Cdh5 knock-out line. An inducible system, based 
on Cre/loxP recombination, was designed to be introduced into the zebrafish genome in the 
form of a bacterial artificial chromosome (BAC). 
 
3.1.1. Design of a VE-cadherin inducible knock-out construct based on Cre-recombinase 
Lox technology 
The initial design of a construct able to knock-out Cdh5 in an inducible manner, consisted of 
the Cdh5 open reading frame (ORF) flanked by loxP sites. The ORF includes all protein-coding 
exons of the endogenous cdh5 gene and its start codon ATG is present at the beginning of exon 
2. Since Cdh5 exon 1 is noncoding, it had not been included in the ORF. To stop transcription 
of the ORF, the SV40 polyA was placed directly after the last exon, exon 13. To visualise Cdh5 
presence, a sequence encoding for the red fluorescent protein mCherry was inserted within exon 
13. More precisely, between the p120-catenin and β-catenin binding sites of the translated 
cadherin protein. This position had been demonstrated before allowing marker fusion proteins 
to be expressed and translated without harming Cdh5 functionality and its design was able to 
rescue Cdh5 mutant phenotypes (Lagendijk et al., 2017). The ORF together with the mCherry 
sequence was flanked by two loxP sites. In the second part of the construct, the loxP-flanked 
mCherry-tagged cdh5 ORF was followed by an mCherry sequence preceded by a nuclear 
localisation signal (nls) and a second SV40 polyA (Figure 1A). 
In absence of Cre-recombinase, this construct expresses cdh5 fused to mCherry. In case of Cre-
recombinase activity, the loxP sites are recombined, resulting in the loss of the complete 
construct located in between. That way Cre-loxP recombination induces Cdh5 knock-out from 
the construct, followed by expression of nls-mCherry under control of the Cdh5 promoter 
(Figure 1A and B). Nls-mCherry serves here as in indicator to visualise those endothelial cells 
(ECs) in which Cre-loxP recombination has occurred. 
 
 
 
Table1. Backbone modification of the Cdh5 containing BAC 
To express this construct in the zebrafish in a most natural way possible, BAC recombineering 
technology was used. This technology allows to exchange the inducible construct for exon 2 in 
a BAC containing the complete zebrafish cdh5 gene. That way, this Bac:lox-Cdh5-lox-nls-I 
construct was expressed under control of the endogenous Cdh5 promoter (Figure 1C). However, 
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in order to make the Cdh5 BAC suitable for injections and further experiments, the BAC 
backbone had to be modified as well (Table1). To get rid of the additional loxP sites present in 
the backbone, a construct containing inverted tol2 sites and β-crystalline:mKate2 eye lens marker 
was recombineered at the former first loxP location. The second loxP site was replaced by an 
AttB site. Tol2 sequences serve as recognition sites for transposon-mediated integration of the 
BAC in the zebrafish genome. The eye marker allows efficient screening to zebrafish embryos 
expressing the BAC construct based on mKate2 expression in their lens. The AttB sites serve 
for phiC31 integrase-mediated attP/attB recombination for site-directed transgenesis into single 
genomic attP landing sites (Mosimann et al., 2013). Since our Cdh5 mutant fish line (UBS8) 
has a null-mutation in its Cdh5 exon 3, BAC Cdh5 exon 3 was removed in order to simplify 
PCR screenings in which UBS8 Cdh5 mutant fish should be distinguished from BAC Cdh5 
inducible mutants (Figure 1C). Backbone modifications procedures and results by BAC 
recombineering are depicted in Appendix-I. 
 
 
Figure 1. Design of the inducible Cdh5 recombination construct and its working 
mechanism. (A) Designed construct to be inserted into the zebrafish genome, which in absence of Cre-
recombinase expresses cdh5 tagged to mCherry. Cre-recombinase activity would result in deletion of 
the mCherry-tagged cdh5 ORF and thereby activation of nls-mCherry expression under Cdh5 promoter 
control. (B) Endothelial cells expressing endogenous Cdh5 and the Cdh5 inducible construct. Cre-
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recombinase activity stops expression of mCherry-tagged cdh5 and induces EC nuclei to express 
mCherry. The latter serves as marker for LoxP recombination. (C) Design of the Cdh5 containing BAC 
with modified backbone. The backbone includes inverted tol2 sites (integration into genome), an 
mKate2 under control of β-crystalline promoter (eye lens marker) and an AttB site (site directed 
integration into genome). In addition, BAC Cdh5 exon 3 was removed. The recombination plasmid 
containing the inducible Cdh5 construct of (A) was exchanged for the BAC Cdh5 exon 2. 
__________________________________________________________________________________ 
 
3.1.2. Replacement of homologous sequences and exchange of the bacterial host prevents 
unwanted autonomous recombination inside the construct 
Prior to microinjection, the engineered Bac:lox-Cdh5-lox-nls-I was tested for correct 
integration of the construct. To this purpose, PCR primers were designed covering the whole 
inducible construct within the BAC (Figure 2A). The results from the PCR reactions proved 
that the region around the first loxP site as well as the complete ORF were present. However, 
reactions towards the 3’ end of the construct did not result in expected product synthesis. 
Reaction C and E did not allow synthesis of PCR products, whereas reaction D yielded a product 
of 300bp instead of the expected 1400bp. Sequencing of the product D indicated that both polyA 
sequences within the PCR product were present, however the loxP and nls-mCherry sequences 
in between were missing (Figure 2A). 
This result suggested that the synthesised recombination plasmid designed in Figure 1 was 
incomplete. When performing PCR B and D on the recombination plasmid itself (the plasmid 
used for the exchange of BAC exon 2), both expected products were yielded. Reaction D, 
however, produced the expected band of 1400bp as well the smaller 300bp product (Figure 2B). 
In addition, the unmodified recombination plasmid, as synthesised and obtained by 
ATG:biosynthetics GmbH, was sequenced, and the results were correct (data not shown). This 
implies that within my host Top10 E. coli population, a mixture of correct and incomplete 
plasmids co-existed. 
Since sequencing of the small product of D showed a loss of the region starting exactly from 
the second loxP site until the last nucleotide of nls-mCherry, autonomous recombination 
between these two identical SV40 polyA sequencing had most likely occurred. Therefore, the 
first polyA sequence was exchanged for the endogenous Cdh5 3’UTR by Gibson cloning (cf. 
2.2.11.). To this purpose, primers were designed in inverted direction around the first mCherry, 
yielding a PCR product of 8675bp. In addition, another PCR product was synthesised consisting 
of the Cdh5 3’UTR flanked with 40bp-long homology arms. Both PCR products were 
subsequently ligated to each other (Figure 2C). Since also the two mCherry sequences are 
identical, the first mCherry was exchanged for tagRFP in a similar way, in order to prevent 
unnecessary sequence repeats within the construct.  
Despite of the removal of mCherry and SV40 homology, the newly designed construct still 
showed autonomous recombination. Sequencing of PCR products demonstrated the loss of the 
region between the two loxP sites (Figure 2D). Also, enzymatic digestion reaction using ScaI 
showed a mixture of correct and incorrect bands within one clonal Top10 E. coli stock (Figure 
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2F). Since exchanging one of the loxP sites was no option with regard to an inducible gene 
knock-out system, the newly designed constructed was purified and retransformed into a 
different host line, called SURE (Stop Unwanted Recombination Events) E. coli (Figure 2E). 
This host lacks components of the pathways that catalyse the rearrangement and deletion of 
nonstandard secondary and tertiary structures, but therefore grows much slower. Screening 
colonies of a re-streak from a recombination plasmid transformed SURE E. coli yielded 
colonies that had incorporated either the correct or the incorrect plasmid, without being mixed 
(Figure 2F). The correct plasmid was now purified from a SURE host and introduced into the 
BAC as in Figure 1C, giving rise to Bac:lox-Cdh5-lox-nls-II. 
 
3.1.3. Introduction of Bac:lox-Cdh5-lox-nls-II into the zebrafish genome leads to 
mCherry expressing EC nuclei 
In order to test whether the newly designed recombination plasmid hosted by SURE E. coli was 
correctly introduced into the Cdh5 BAC, XbaI digestion on purified Bac:lox-Cdh5-lox-nls-II 
was performed, together with the BACs at former designal stages. All expected digest products 
can be found in the electrophorese result (Figure 3A). Finally, the BAC was retransformed in 
DH10B E. coli, the usual host cells for long term BAC storage. DH10B cells do not have the 
heat-shock inducible genes coding for homology recombination facilitating proteins. This 
might reduce unwanted recombination events of the final engineered BAC, caused by potential 
background activities of those proteins. 
Three days upon injection of the BAC into zebrafish zygotes, 80% of the survived embryos 
showed red eyes under the binocular. However, further screening under the confocal 
microscope revealed that in none of these fish Cdh5 was visible. Moreover, in 74% of the 
embryos with red eyes, the nuclei of endothelial cell expressed mCherry (Figure 3B), meaning 
that somehow the construct did not allow Cdh5-tagRFP synthesis and/or could not prevent nls-
mCherry expression in absence of Cre-recombinase. To ascertain that in the genome integrated 
and expressed inducible construct was still intact, genomic DNA from embryos with red eyes 
was extracted and checked by PCR. In all examples, the Cdh5 ORF tagged with tagRFP and 
followed by nls-mCherry were present (Figure 3C). 
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Figure 2. Exchange of homologous sequences and plasmid bacterial host to prevent 
unwanted autonomous recombination. (A) PCR results using primers covering the inducible 
mCherry-tagged Cdh5 construct within the BAC. Product A (1500bp) and product B (2000bp) were 
obtained. Products C (1800bp) and E (1500bp) were not amplified, whereas reaction D (expected to be 
140bp) resulted in a smaller product of 300bp. Sequencing of product D revealed that D consists of both 
polyA sequences but lacked the loxP and nls-mCherry (B) PCR reactions performed on the 
recombination plasmid. Products B (2000bp) and C (1800bp) were present, however, for reaction D 
both the expected (1400bp) as well as a short product (300bp) similar to (A) were synthesised. (C) New 
design of the recombination plasmid in which mCherry was exchanged for tagRFP by Gibson cloning. 
In addition, the first polyA was exchanged for the Cdh5 endogenous 3’-UTR by the same technique (not 
shown in this figure). (D) New design of the recombination plasmid after Gibson cloning. Sequencing 
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of the plasmid showed that also the two loxP sites underwent autonomous recombination when hosted 
in Top 10 E.coli. (E) The newly designed plasmid was transformed into SURE (Stop Unwanted 
Recombination Events) E. coli to prevent further autonomous recombination events. (F) NcoI and ScaI 
enzymatic digestion reactions of the recombination plasmids hosted by both Top10 and SURE E.coli. 
Impurity of plasmids in Top10 after Gibson cloning was clearly visible.  Sample 1 from the SURE host 
showed a pure clonal recombination plasmid after its redesign by Gibson cloning, based on the expected 
digestion bands (red box). The NcoI and ScaI cutting sites within the inducible construct are indicated 
in (D) and (E). For the gels in A, B and F a 100bp DNA ladder was used. 
__________________________________________________________________________________ 
 
 
Figure 3. EC nuclei expressing mCherry after introduction of the inducible Cdh5 BAC 
into the zebrafish genome. (A) XbaI digestion of Bac:lox-Cdh5-lox-nls-II showing all expected cut 
products through the different designal stages of the BAC. The bands a to f on the gel correspond to the 
elements with the same letter indicated in the plasmid. A 1kb DNA ladder was used here. (B) 
Introduction of the inducible Cdh5 BAC into the zebrafish genome led to embryos with red eyes and 
mCherry (indicated here in green) expressing EC nuclei. (C) The inducible Cdh5 construct including 
the tagRFP and nls-mCherry coding sequences were present in BAC-injected zebrafish showing red 
eyes. PCR with the indicated primers generated a 1000bp product. For this gel a 100bp DNA ladder was 
used. 
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3.1.4. Transcriptional read-through of the Bac:lox-Cdh5-lox-nls-II construct causes 
expression of mCherry in ECs 
A closer look at the original design of Bac:lox-Cdh5-lox-nls-II reveals that the region between 
the second loxP site and nls is identical to the end of intron 1. Within these intron ends a splicing 
acceptor sequence is present, controlling the elimination of the intron during RNA processing.  
Due to the fact that nls-mCherry was expressed in absence of cre-lox recombination, I 
hypothesised that the newly introduced 3’UTR did not stop transcription efficiently enough. As 
a consequence, transcription continued towards mCherry, whereupon the second exon 1 splice 
acceptor caused an alternative splicing event between Cdh5 exon 1 and nls (Figure 4A). This 
would lead to mRNA that only encodes for nls-mCherry, whereas our predicted mRNA should 
only contain a transcription of cdh5 fused to tagRFP. 
In order to check this hypothesis, RNA was extracted from BAC-injected embryos expressing 
mKate2 in their eye lenses, as well as from BAC-injected embryos without red eyes as a control. 
The purified RNA served as a template for reverse transcription (RT) to synthesise cDNA, using 
RT primers starting at tagRFP, mCherry and polyA sequences (Figure 4B, red arrows). PCR 
analysis on the revealed expected product synthesis of RFP and mCherry (Figure 4B, primers 
indicated as blue arrows). A third triple primer pair was designed (PCR1) binding in forward 
direction to exon 1 and ORF exon 13/3’-UTR, and in reverse direction to mCherry. Since exon 
1 and mCherry are located 4550bp from each other (whose PCR product would be too long to 
be synthesised during a 30-sec extension time), this PCR reaction should only synthesise a 1500 
product between exon 13/3’-UTR. However, cDNA generated using RT primer oligo-dT 
(leading to synthesis of all mRNA within the zebrafish sample) also yielded a product of 700 
bp, which can only be generated between the primers binding exon 1 and mCherry, in case of 
alternative (unpredicted) splicing (Figure 4B). The fact that the other PCR products expected 
from the desired transcription splicing are synthesised as well, points to an amplification of 
genomic DNA, which had not been entirely removed by DNases during cDNA synthesis 
procedure. 
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Figure 4. cDNA analysis to investigate potential alternative splicing. (A) Prediction of splicing 
products with regard to two possible splicing events during mRNA processing. In case of transcription 
read-through of the construct, mature mRNA encodes for nls-mCherry, whereas tagRFP-tagged Cdh5 
ORF gets lost. (B) Primer design for reverse transcription (red arrows), followed by PCR primers (blue 
arrows) and electrophorese set-up in order investigate splice variants using cDNA from BAC injected 
embryos (with red eyes) as a template. PCR1 on oligo-dT samples could only yield a 700bp product 
(surrounded by red circle) in case of splicing from read-through transcription. Other PCR products were 
obtained either due to amplification of genomic DNA still present in the cDNA synthesis mix or, less 
probably, due to both splicing variant events happening at the same time. For this gel a 100bp DNA 
ladder was used. 
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3.1.5. Improved design of the inducible BAC by inversion of nls-mCherry-polyA-loxP 
ensures expression of RFP-tagged Cdh5 
In order to prevent alternative splicing by read-through transcription, nls-mCherry-polyA-loxP 
part was newly designed, more precisely it was inverted. In addition, the 3’-UTR was replaced 
for rabbit β-globin 3’UTR, which had been shown before to efficiently terminate RNA 
transcription (Gil and Proudfoot, 1987). Cre recombination of two loxP sites oriented in the 
same direction, leads to excision of DNA between both sites. In this case, when a second loxP 
site is oriented in the opposite direction, recombination inverses the cassette between the loxP 
into the opposite orientation (Figure 5A). In absence of Cre-recombinase, the Cdh5 ORF 
including the tagRFP should be transcribed and translated. In this configuration, no other splice 
acceptor sites within the construct are present anymore. Flipping of the construct into opposite 
direction, should bring nls-mCherry under control of the Cdh5 promoter, which consequently 
should lead to mCherry expression in EC nuclei and no transcription of the Cdh5 ORF anymore 
(Figure 5A).  
The nls-mCherry-polyA-loxP cassette in inverted orientation linked to the rabbit β-globin PolyA 
in normal orientation was synthesised by ATG:biosynthetics GmbH. By BAC recombineering 
technology, this cassette was then exchanged for the sequence of 3’-UTR up until the second 
loxP site in the former BAC design. Initially, BAC recombineering did not work anymore due 
to unstable biotin indispensable for SW102 cells to grow (appendix II). After having solved this 
problem, the new cassette had been introduced to Bac:lox-Cdh5-lox-nls-II to give rise to 
Bac:lox-Cdh5-inls-ilox and their SW102 E. coli clones were screened by PCR for having the 
new construct. The PCR products of correct ones were sequenced (Figure 5B). Finally, after 
purification of a correct Bac:lox-Cdh5-inls-ilox, it was further tested by PCR for the modified 
backbone elements (cf. Appendix I) and for the inducible construct similar as in Figure 2B 
(Figure 5C up). In addition, the new BAC was digested by XbaI, yielding all expected bands 
(Figure 5C down). From the moment all testing results were positive, the selected BAC was 
prepared for injection. 
Injection of the BAC resulted in some embryos expressing red eyes (Figure 5D), whose ECs 
showed tagRFP expression at junction, e.g. in the dorsal aorta (Figure 5E). However, in certain 
embryos tagRFP expression was not exclusively restricted to junctions, but some EC nuclei 
seemed to express tagRFP as well, which I will further investigate once I have identified 
founder fish (Figure 5F). The presence of the complete construct in the genomes of two BAC-
injected embryos were confirmed by PCR tests (Figure 5G). In order to test the functionality of 
the construct further, the BAC was injected into zygotes expressing Cre recombinase under 
control of the kdrl promoter. In this case, one would expect the recombination of the loxP sites 
in all ECs resulting in the inversion of the construct between the loxP sites. In this case, nls-
mCherry should be expressed under control of the Cdh5 promoter, as indeed was observed in 
some BAC-injected kdrl:cre;kdrl:gfp embryos (Figure 5H). 
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Figure 5. Redesign of the inducible BAC to prevent splicing from read-through 
transcription. (A) In the new design, nls-mCherry-polyA-loxp sequences were inverted. In addition, 
Cdh5 3’UTR has been replaced for rabbit β-globin polyA (Rb Glob PolyA). In absence of Cre 
recombinase activity, transcription should stop after (Rb Glob PolyA) without further possible splicing 
variants during mRNA processing. At the moment Cre recombinase recombines the now inverted 
oriented loxP sites, the construct between the loxP sites will be inverted, resulting in nls-mCherry 
expression under control of the Cdh5 promoter. (B) The RBpolyA- (i)SV40polyA-(i)nls-(i)mCherry-
(i)loxp has been synthesised and exchanged for 3’UTR until the second loxP site by BAC 
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recombineering. Re-engineered clones were screened by PCR and checked by sequencing for correct 
integration. (C) Further PCR tests on the final designed purified BAC including the modified elements 
in the backbone (cf. Appendix I) and covering the inducible cassette identical to Figure 2B. Finally, 
XbaI digest showed all expected cut products. (D) Bac:lox-Cdh5-inls-ilox-injected embryo showing red 
eyes. (E) TagRFP expression in junctions within the DA of a Bac:lox-Cdh5-inls-ilox-injected embryo. 
(F) TagRFP expression in junctions within the ISVs of a Bac:lox-Cdh5-inls-ilox-injected embryo. Some 
nuclei seemed to express tagRFP (white arrow). (G) Genomic DNA of two BAC-injected embryos were 
tested by PCR similar to (C) for presence of the complete construct in their genomes, which was the 
case. (H) Kdrl:cre;kdrl:gfp embryos were injected with the inducible cdh5 construct as well. Cre 
recombination of the loxP sites led to the expression of nls-mCherry in the nuclei of endothelial cells 
(here in SIVs). DA: dorsal aorta; ISV: intersegmental vessel; SIV: subintestinal vessel. 
__________________________________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
63 
 
3.2. Generation of a photo-convertible fluorescent protein-tagged Cdh5 line 
 
Photo-convertible fluorescent proteins are proteins that have the capability of irreversibly 
switching their emission colour from green to red, when exposed to light of approximately 
400nm (Hoi et al., 2010). In order to obtain a zebrafish line, in which Cdh5 can be visualised 
from individual neighbouring endothelial cells, a BAC construct was designed in which Cdh5 
is fused to the photo-convertible fluorescent protein mClavGR2 (further indicated as mClav). 
To this purpose, mClav was introduced by BAC recombineering technology into the exon 13 
of cdh5, between the p120-catenin and β-catenin binding sites of the translated cadherin protein 
(Figure 6A). This position has been demonstrated before allowing marker fusion proteins to be 
expressed and translated without harming Cdh5 functionality (Lagendijk et al., 2017). The 
Cdh5 parental BAC (therefore with the modified backbone, cf. Appendix IB) with the cdh5 
gene still completely intact (including exon 3), was reused for this BAC recombination 
procedure.  
After recombineering, SW102 colonies were screened for correct BAC clones and correct ones 
were purified. The selected cdh5-mClav containing BAC was subsequently tested by XbaI 
digest, further PCR analyses (Figure 6B) and sequencing. From the moment one BAC was 
positive for all testing results, it was prepared for injection into zebrafish zygotes. 
Injection of wild type zebrafish zygotes resulted in roughly 60% of the surviving embryos that 
showed red eyes, from whom 70% expressed mClav-tagged cdh5 in endothelial cells. mClav 
was excited by a 488nm laser beam and indicated Cdh5’s localisation in the green channel, as 
shown here in the subintestinal plexus of a 2dpf embryo (Figure 6C, left upper panel). mClav 
can be converted by 405nm laser light (20% laser intensity for 1min), which resulted in mClav 
light emission in the red channel after excitation by 561nm laser (Figure 6C, lower panels). In 
this case, the green signal decreases, which makes this tool appropriate for studying the 
contribution of Cdh5 from different individual ECs to the establishment of adherens junctions.  
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Figure 6. Design of a photo-convertible fluorescent protein-tagged Cdh5 and its 
expression. (A) Design and strategy of the Cdh5 BAC in which mClav has been introduced within 
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Cdh5 exon 13 by BAC recombineering technology. The Cdh5 BAC with the modified backbone has 
been reused from the Cdh5 inducible knock-out project (cf. Figure 1C). (B) Correct engineering of 
mClav-tagged cdh5 BAC shown by XbaI digest (cf. Figure 3A) and PCR. PCR amplication products 
were obtained from the sequences coding for mClav (a 925bp product), Cdh5 exon 3 (750bp), AttB 
(300bp) and Tol2 (560bp). For the gel containing the digest, a 1kb DNA ladder was used, for the PCR 
analysis a 100bp ladder. (C) Injection of mClav-tagged Cdh5 BAC led to expression of Cdh5 marked 
by mClav in ECs. Initially, mClav was visualised when exited by laser of 488nm (C upper left panel). 
After conversion by a 405nm laser beam, the green signal decreased whereas the converted mClav 
became visible in the red channel excited by a 561nm laser light (C lower panels). The vessels depicted 
here are sub-intestinally located. 
__________________________________________________________________________________ 
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3.3. Phenotypic characterisation of RadilB during vascular morphogenesis 
 
Since Rasip1 is known to be essential for proper Cdh5 localisation and its absence results in 
abnormal blood vessel development, other related proteins were searched. Radil was found to 
be a closely-related protein and is used in this study to understand EC behaviour in vivo during 
ISV development. 
  
3.3.1. Amongst the three duplicated radil genes only radilb is specifically expressed in the 
endothelium 
Protein-protein blasting of Rasip1 zebrafish protein sequence against Danio rerio (taxid:7955) 
database reference proteins (refseq_protein) of NCBI resulted in three protein suggestions 
sharing similar protein domains: Radil, si:ch73-281f12.4 and si:ch211-176g6.2. Since the two 
non-annotated proteins contain the same protein domains and a similar architecture, I call 
si:ch73-281f12.4 RadilB and si:ch211-176g6.2 RadilC. Although in human and mice only one 
radil gene is known, it seems that radil in zebrafish has undergone gene duplication events 
during teleost evolution. Moreover, their typical domains (ras associating domain, forkhead 
associated domain, dilute domain and PDZ domain) have been preserved. Only the first three 
mentioned protein domains are shared with Rasip1 (Figure 7A).  
In zebrafish, only the annotated Radil (from now on RadilA) has been examined. Knockdown 
of RadilA results in multiple defects in neural crest-derived lineages such as cartilage, pigment 
cells, and enteric neurons (Smolen et al., 2007). However, no defects with respect to 
angiogenesis nor to EC homeostasis have been described yet. 
Zebrafish Rasip1 shares a common ancestor with the mammalian human and mouse Rasip1, 
when plotting their protein sequence comparison in a phylogenetic tree (Figure 7B). Human 
and mouse Rasip1 are closely related given their short branch length. In contrast, the branch 
length of zebrafish Rasip1 indicates a farther distance to its mammalian homologue. Zebrafish 
RadilA, however, shows a much closer relationship with regard to its mouse and human 
homologue, but this is not the case for zebrafish RadilB and C. The latter share a common 
ancestral precedent, before their phylogenetic branches converge with the one of RadilB and 
mammalian Radil (Figure 7B). Most probably, genetic duplication of Radil in teleost evolution 
took place twice. First, between RadilA and RadilB-C, later between RadilB and RadilC. 
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Figure 7. Gene duplication analysis for Radil in zebrafish. (A) Three different Radil genes are 
present in the zebrafish genome. All three share three common protein domains with Rasip1: Ras 
68 
 
associating domain (green), forkhead associated domain (blue) and the dilute domain (yellow). In 
addition, Radil proteins contain a PDZ domain (white). (B) Phylogenetic tree of Radil and Rasip1, 
showing their respective evolutionary relationship. Zebrafish Rasip1 has the same ancestral provenance 
as the mammalian mouse and human Rasip. Same is true for zebrafish RadilA. Zebrafish RadilB and C, 
however, are closer related to each other, but at larger distance from mouse and human Radil than 
zebrafish RadilA. (C) In situ hybridisation demonstrates that only radilb is endothelial specifically 
expressed. Hybridisation was performed on 28hpf fixed embryos. Only antisense probes are reversibly 
complement and can therefore bind to its corresponding mRNA. The probe against the endothelial 
specific Fli mRNA is used as positive control (left panel). 
___________________________________________________________________________ 
 
In order to find out which of the found Radils in zebrafish were of any interest to examine 
endothelial cell behaviour, in situ hybridisation on 28hpf embryos was performed. To this 
purpose, dig-labelled probes were made using exon 5 as a template, since this exon was longest 
in all three Radils. Only RadilB showed an endothelial specific expression, whereas RadilA and 
RadilC mRNA was ubiquitously present, although in low quantities (Figure 7C). The result of 
RadilA sample is in accordance with supplemental Figure 3 from Smolen et al., 2007. In mouse, 
Radil is rather ubiquitously expressed with enrichment in the lung and testis (Yue et al., 2014). 
RadilB in zebrafish shows highest protein similarity with mouse Radil based on the percentage 
to which both protein sequences resemble. On the contrary, less resemblance is calculated for 
zebrafish RadilA and RadilC (Table2). All these findings together made RadilB an interesting 
candidate for phenotypic analysis on vascular morphogenesis. 
 
Table 2. Protein resemblance between RadilB and its homologues in zebrafish, mouse and human
 
3.3.2. Null-mutation in one allele coding for RadilB does not affect angiogenesis 
A zebrafish line containing a null-mutation for RadilB was ordered at ZIRC. By N-ethyl-N-
eitrosourea (ENU) mutagenesis screens a mutant line was selected having a T to A point 
mutation close to the gene’s 5’-end. This mutation converts the tyrosine-129 codon into a stop 
codon, leading to the loss of all functional domains (Figure 8A). Using a four primer PCR 
strategy, wild type, hetero- and homozygous fish can be distinguished from each other. For this 
genotyping procedure, two outer primers bind 600bp away from each other around the 
mutation. Two inner primers recognise either the wild type allele or the mutant allele, for which 
the wild type primer generates a 400bp product and the mutant one a 200bp PCR product 
(Figure 8B left panel). The effectiveness of this genotyping strategy was initially confirmed by 
genotyping (Figure 8B right panel). 
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Crossing of RadilB mutant fish to endothelial marker lines allows phenotypical analysis within 
the process of angiogenesis. In order to examine mutant embryos, having the exact same genetic 
background and laid at the same time, heterozygous mutant marker lines were incrossed. Their 
offspring was selected for carrying the homozygous mutation. Homozygous RadilB mutant fish 
are viable and fertile. In the set-up of this study, homozygous fish were crossed to heterozygous 
ones in order to obtain embryos with identical parental background, but carrying the RadilB 
mutation on either one or both alleles (Figure 8C).  
Phenotypical analysis by comparison can only occur in case the heterozygous fish show no 
phenotype. Therefore, heterozygous marker lines were crossed with wild type fish and their 
offspring analysed for abnormalities in the context of angiogenesis, including collapsing ISVs, 
retracting ISVs, aberrant cell wall architecture and delays in development. As an example, at 
50hpf no differences in blood vessel architecture nor developmental delays between 
heterozygous mutants and wild types were visible (Figure 8D). In addition, quantification of 
the incidence of angiogenic abnormalities during embryonic development from 24hpf up to 
3dpf did not show significant differences between both genotypes (Figure 8E, N=21, P=0.854). 
Therefore, heterozygous RadilB mutants were used in this study as a control reflecting the wild 
type for further phenotypical analyses of RadilB. 
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Figure 8. Characterisation of the mutation in the gene coding for RadilB. (A) Location of 
null-mutation within the RadilB protein sequence. ENU mutagenesis screens selected a T to A point 
mutation, resulting in the conversion of the codon for tyrosine-129 into a stop codon. This results in the 
loss of translation of all functional domains. (B) Genotyping strategy using four primers that can 
generate a control big product, and a smaller wild type respectively mutant band, or both. Effectiveness 
of the screening strategy checked by genotyping. The outer primers generate a control PCR product of 
600bp, the inner primers a product of 400bp (wild type allele) or 200bp (mutant allele) respectively. (C) 
Crossing scheme for used experimental set-up. Mutants were crossed with marker line, here 
demonstrated for kdrl:gfp, to get heterozygous RadilB marker lines. Subsequent incross yielded 
homozygous RadilB marker lines. For the experiment set-up, heterozygous mutants were crossed with 
homozygous mutants to obtain 50% homo. and 50% het. offspring with same genetic background. (D) 
Heterozygous kdrl:gfp mutants do not show any phenotypes in blood vessel architecture and delays in 
vessel development at 50hpf. (E) Quantification of angiogenic abnormalities observed in heterozygous 
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kdrl:gfp mutants from 24hpf to 3dpf. Observations include collapsing ISVs, retracting ISVs, aberrant 
cell wall architecture and delays in development. The un-paired Mann Whitney test was used as 
statistical test. 
__________________________________________________________________________________ 
 
3.3.3. Absence of RadilB causes intermittent lumen collapses during ISV maturation and 
abnormalities in blood vessel architecture at later developmental stages 
Crossing of radilb+/-;kdrl:gfp with radilb-/-;kdrl:gfp yielded embryos from whom 50% were 
homozygous and 50% heterozygous. When the dorsal longitudinal anastomotic vessel (DLAV) 
in homozygous was being formed, the initial formed lumen within the intersegmental vessels 
(ISV) suddenly collapsed and reopened again (Figure 9A). This intermittent lumen collapse 
was observed within radilb-/- at a higher percentage (22.9% of the ISVs) than in radilb+/- 
embryos (10.2% of the ISVs) (Figure 9E, N=17, P=0.0284). 
To better understand what exactly happened during an ISV collapse, time lapse imaging at 
higher magnification recorded several intermittent lumen collapses in more detail. These 
collapses only occured when at least two biological processes coincide: 1. the ISV undergoes 
an arterial to venous transition and 2. the ISV cell divides. The arterial to venous transition 
happened to approximately 50% of all ISVs, since initially these vessels grow as arteries (cf. 
1.1.2.4.). During this transition, a secondary spout from the post cardinal vein (PCV) grows out 
and anastomoses with the ISV initially bound to the dorsal aorta. This phenomenon was clearly 
visible in Figure 9B and upon cell division of this particular vessel, the lumen collapsed. After 
finishing the venous formation, the lumen inflated and reopened. 
Since RadilB is apparently indispensable for stable vessel lumen maintenance during arterial to 
venous transition, RadilB might have an influence on the amount of arterial versus venous ISVs 
formed during angiogenesis. However, counting of the amount of arterial versus venous ISVs 
at 55hpf did not show any significant differences between homozygous mutant and wild type 
embryos (Figure 9D, N=19, P=0.7750). 48.9% Of the wild type ISVs and 46.7% of the mutant 
ISVs were counted to be arterial. Thus, RadilB does not seem to have any influence on arterial 
versus venous cell fates. 
At later stages during embryonic development, the ISVs of homozygous mutants showed an 
abnormal vessel wall architecture. Vessel walls of radilb-/- embryos were less smooth, rather 
jagged, in comparison to radilb+/-. In addition, ISV show patterning problems at the place 
where the venous ISV had anastomosed to secondary sprouts from the PCV (Figure 9C). 
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Figure 9. Intermittant lumen collapses and patterning problems in RadilB homozygous 
mutants. (A) Time-lapse imaging from 30 to 45hpf of radilb-/-;kdrl:gfp embryos showed intermittent 
lumen collapses during ISV maturation. The white arrow indicates the place of cell division from the 
vessel that undergoes the lumen collapse (B) A closer look radilb-/-;kdrl:gfp during an intermittent lumen 
collapse revealed that initially a lumen within the ISV had been formed, but collapsed at the moment 
the initial arterial vessel was transitioned into a venous vessel and simultaneously started to divide. After 
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cell division, the lumen opened again. The white arrow indicates the emerging venous secondary sprout. 
(C) At 50 and 60hpf the blood vessel wall architecture of radilb-/-;kdrl:gfp embryos show abnormalities. 
In homozygous mutants the vessel walls are less smooth (rather jagged) and patterning problems occur 
where the ISV get connected to the PCV. (D) The amount of arterial versus venous ISVs does not differ 
at 55hpf between hetero- and homozygous RadilB mutants. (E) Quantification of the amount of 
intermittent lumen collapses in radilb-/- and radilb+/- embryos (N=17). The un-paired Mann Whitney 
test was used as statistical test. 
___________________________________________________________________________ 
 
3.3.4. RadilB mutants show arterial venous shunt formations during arterial to venous 
transition and reduced cell divisions during ISV outgrowth 
To evaluate whether the arterial to venous transition in mutants caused problems for blood cell 
perfusion, Δradilb;kdrl:gfp mutants were crossed with a gata1:dsRed line, allowing visualisation 
of red blood cells. The onset of blood perfusion in homozygous mutant ISVs took in average 
place around 42hpf, whereas in heterozygous mutant perfusion started around 40hpf. 
Remarkably, homozygous mutants showed shunt formations at the moment venous to arterial 
transition occurred. Sometimes, when a venous secondary sprout anastomosed with an ISV, the 
ISV kept contact to the dorsal aorta, thereby enabling blood cells to move from the aorta via 
the shunt directly into the PCV, thereby omitting the DLAV (Figure 10A). This was observed 
in 28.6% of the analysed mutants ISVs. However, a closer look to heterozygotes revealed that 
this shunt formation also occurred (in 7.1% of the analysed ISVs), albeit less pronounced. 
Considering the amount of shunt incidences, no significant differences between both genotypes 
were observed (Figure 10C, P=0.0758). This might be partly due to a too limited sample size 
(N=11). 
Since the absence of RadilB seemed to cause problems in vessel stability (cf. Figure 9B) and 
patterning during arterial to venous transition (cf. Figure 10A and 9C), I hypothesised that a 
reduction of ECs within the ISV might be an underlying problem. Therefore Δradilb mutants 
were crossed with a kdrl:gfp-nls to visualise EC cell divisions. During sprout outgrowth (24-
32hpf) ECs in ISVs of homozygous RadilB mutants clearly underwent less cell divisions than 
in heterozygotes (Figure 10B and D, N=19, P=0.0188). In 44.6% of the analysed heterozygous 
ISVs, a cell division takes place, compared to 13.7% of the ISVs in homozygous mutants. 
Consequently, maturing ISVs in homozygous RadilB mutants must consist of less individual 
ECs than in those with a heterozygous background. 
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Figure 10. Arterial-venous shunt formations and reduced cell divisions in RadilB mutants. 
(A) Time-lapse images of hetero- and homozygous Δradilb;gata1:dsRed;kdrl:gfp showing the flow of 
red blood cells (red) through ECs (green). In homozygous mutants, arterial-venous shunt formations 
seemed to occur more frequently, although difference between hetero- and homozygotes are not 
significant (C). (B) Time-lapse images of hetero of ΔradilB;kdrl:gfp-nls showing cell divisions of EC 
nuclei (green) during ISV outgrowth. ECs in RadilB homozygous mutants underwent less cell divisions. 
(C) Quantification of the amount of cell formations in hetero- and homozygous mutants. The incidence 
of shunt formations showed a tendency to be higher in homozygotes, but could not be confirmed by 
statistical analysis (P=0.0758, N=11). (D) Quantification of the amount of cell divisions in hetero- and 
homozygous mutants. The incidence of cell division was significantly lower in homozygotes (P=0.0188, 
N=19). The un-paired Mann Whitney test was used as statistical test. 
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3.3.5. Cdh5 in RadilB mutants shows an abnormal localisation 
In order to figure out the role of adherens junctions underlying the observed phenotypes in 
RadilB mutants, including the intermittent lumen collapses and shunt formations during arterial 
to venous transformation, the localisation of Rasip1 and Cdh5 in mutants was examined. Rasip1 
localised in wild type embryos in continuous lines, restricted to endothelial cells (Figure 11A). 
At 32hpf Cdh5 was confined to Rasip1 localisation, but Rasip1 lines were also observed at 
locations where Cdh5 was not present (white arrows). 
Concerning the localisation of RadilB itself during vascular development, I designed potential 
target peptides for antibody generation against RadilB. Two peptides were injected into rabbits 
and their generated antibodies were harvested and are still in testing phase (cf. appendix-III for 
the peptide design and first staining results). 
Double antibody stainings against Cdh5 and Rasip1 at 32hpf-fixed mutant embryos showed 
first of all that the localisation of Rasip1 protein was not influenced by the absence of RadilB 
(Figure 11A, Rasip1 in red). However, differences between hetero- and homozygous mutants 
became clear at the level of Cdh5. Within the homozygous mutant ISVs, Cdh5 did not localise 
in a continuous way along the adherens junctions (Figure 11B, Cdh5 in green). In addition, the 
adherens junctions looked less enriched with Cdh5 within these cells (Figure 11B, 
magnification panel, see white arrows, N=8). 
To visualise Cdh5 presence at later stages, the RadilB mutant line was crossed into the Cdh5 
tension sensor line (Lagendijk et al., 2016), whose fluorescent Venus tag was used here as a 
marker for Cdh5 localisation. At 48hpf, adherens junctions showed now continuous presence 
of Cdh5 in both mutant lines. Some ISVs in homozygous embryos, however, had junctional 
lines that were detached from the dorsal aorta or PCV (Figure 11C, arrow in the middle), 
thereby forming ISVs that were partly unicellular. In addition, Cdh5 in homozygous mutant 
ISVs were localised in patches that had apparently not succeeded to align into elongated 
adherens junctions. 
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Figure 11. Aberrant junctional shapes in RadilB mutants. (A) In wild type, Rasip1 was localised in 
ECs in continuous lines, overlapping but not restricted to Cdh5 (white arrows indicate Cdh5-less Rasip1 
localisation. (B) Antibody stainings against Rasip1 (red) and Cdh5 (green) on at 32hpf fixed embryos. 
Blue is endogenous expressed kdrl:gfp. Localisation of Rasip1 was normal in both hetero- and 
homozygous mutants, however, Cdh5 showed a less linearized accumulation at the adherens junctions 
in homozygous mutants (white arrows). Consequently, adherens junctions did not look like continuous 
lines. (C) Localisation of Cdh5 at 48hpf visualised by a venus-tagged Cdh5 marker line. Cdh5 in 
homozygous mutant ISVs showed sometimes a detached localisation in which parts of ISV had a 
unicellular configuration (arrow in the middle). In addition, unaligned patches of Cdh5 were visible 
within homozygous mutants as well (arrow upper left). Figure 11C was provided by Minkyoung Lee.   
77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
78 
 
Chapter IV  
Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
79 
 
4.1 Generation of an inducible Cdh5 knock out line 
 
The major focus of my thesis was to create tools that would enable us to decipher cytoskeletal 
junctional interactions during blood vessel morphogenesis. To this purpose, I generated an 
inducible Cdh5 knock out line that can be used to remove cdh5 expression at any given time 
point during embryonic development, based on Cre/loxP recombination. The modifications of 
the Cdh5 gene were executed by BAC recombineering technology, whose design was optimised 
over time, based on learning by doing. Finally, the most optimal design proposed in this thesis 
is based on inverted loxP sites flanking the RFP-tagged open reading frame of Cdh5 and an nls-
mCherry in opposite direction. Introduction of this design into the genome of the zebrafish led 
to expression of cdh5 in Cre-less fish as well as nuclear mCherry expression in case of active 
Cre recombinase. 
 
4.1.1. Optimisation of BAC recombineering 
Since BAC recombineering was not performed in the lab before, the technique had to be 
established first. First recombination attempts seemed to be only successful in case the PCR 
product was clean enough and completely deprived of its template. Therefore, PCR synthesis 
needed to be optimised for every individual insert in order to generate one single product 
without any side products. In addition, proper DpnI treatment of the PCR mix was 
indispensable. The efficiency of generating a clean insert was more crucial than any other 
parameter of the technical procedure. On the contrary, the length of the insert (I used up to 
7000bp) did not form any limitation for recombination to happen. BAC recombineering also 
requires working with freshly prepared biotin and deoxy-galactose. Both ingredients turned out 
be unstable when stored in solution over periods longer than four months. A lot of time was lost 
when all ingredients had to be tested when recombination within the BAC did not take place. 
In general, I optimised the complete procedure as described in section 2.2 including the 
generation of the insert, the preparation of different agar plates and the recombineering 
procedure. This thesis can therefore be used a guide for future genetic editing by BAC 
recombineering adapted to our lab.  
 
4.1.2. Homologous sequences should be avoided 
A big problem when hosting large constructs in E. coli are homologous sequences. Principally 
within the standard Top10 E.coli cells, constructs with homologous sequences undergo 
autonomous recombination, even sequences as small as 33bp-loxP sites. Avoidance of 
homology within the construct design is recommendable, although one could use SURE E. coli 
instead. However, SURE E. coli grow very slowly and cannot be used for kanamycin selection. 
Autonomous recombination within SW102 E. coli cannot be excluded based on my results. 
Since λ-prophage based recombination is based on homology, one should preferably, also 
within BAC hosts, limit homologous sequences to a minimum. 
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4.1.3. BAC recombineering is slow but allows insertion of large constructs in a 
controlled way 
Executing one modification within a BAC will take three weeks when all steps are optimised 
and successful. Principally the growth speed of SW102 bacteria limits time efficiency. Another 
disadvantage might be some background activity of the defective λ-prophage system, which 
might not be completely switched off at 32°C. Especially BACs in SW102 that have been at an 
incubation temperature of 37°C should not be used anymore, because the λ-prophage system 
might have caused background mutations. A simple way to avoid this problem is the 
purification of the BAC from the SW102 and its retransformation into DH10B E. coli. DH10B 
is the standard host for BACs and does not contain a λ-prophage-based recombineering system. 
The main advantage of BAC recombineering is that one can insert big inserts in a site-specific 
way, which cannot be done by CRISPR/Cas9 gain-of-function approaches. Each step during 
the DNA modification process can be controlled be negative as well as positive selection. 
Consequently, once a certain step does not work, one should not start from the very beginning 
and only needs to optimise that particular step. In addition, I chose to modify cdh5 in the Cdh5 
BAC, because that way I could keep the endogenous promoter and enhancers of cdh5. When 
introducing the Cdh5 containing BAC in the genome, the gene expressing regulation is still 
present and identical to the endogenous cdh5.  
 
4.1.4. Transcriptional read-through might have been due to incomplete Cdh5 3’-UTR 
To prevent autonomous recombination between the identical SV40-polyA tails of cdh5 and 
mCherry within the construct, the polyA tail of cdh5 was replaced by the Cdh5 3’-UTR. After 
injection of Bac:lox-Cdh5-lox-nls-II in which homologous sequences were replaced, embryos 
expressed mCherry in the nuclei of their ECs in absence of Cre. Because the construct was 
completely integrated in the genome, but its matured mRNA did not contain cdh5-tagRFP, I 
concluded that cdh5-tagRFP in the RNA was lost by transcriptional read-through. This 
observation indicated that the Cdh5 3’-UTR was not capable enough to stop transcription after 
the open reading frame of cdh5. Since the 3’-UTR of cdh5 has not been annotated yet, the 3’-
end sequence, found in the cDNA of the Cdh5 after the last coding exon, was taken. A 
functional terminator of transcription needs a polyadenylation signal (AAUAAA), a cleavage 
signal (CA) and a GU-rich sequence, so that proteins can bind the 3’-end of the RNA and add 
to polyA tail important for mRNA stability and localisation (Figure D-I). However, during this 
process of mRNA maturation, the 3’-UTR is cleaved at the cleavage signal. When generating 
cDNA from mRNA, one loses therefore the GU-rich sequence. Indeed, within the sequence of 
the 3’-UTR used in our construct, polyadenylation signals were present, but the GU-rich 
sequence was lacking, which could explain that the used Cdh5 3’UTR was incomplete and 
therefore did not stop transcription.  
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Figure D-I. The pre-mRNA 3′ processing complex. A functional terminator of transcription needs a 
polyadenylation signal (AAUAAA), a cleavage signal (CA) and a GU-rich sequence, so that proteins 
can bind the 3’-end of the RNA and add the polyA tail important for mRNA stability and localisation. 
The most important binding proteins include Cleavage and Polyadenylation Specific Factor (CPSF), 
Poly(A)polymerase (PAP) and Cleavage Stimulating Factor (CstF). Adapted from Di Giammartino and 
Manley, 2014. 
__________________________________________________________________________________ 
 
4.1.5. Establishment of a stable inducible Cdh5 line 
In order to gain a stable zebrafish line, the BAC-injected fish need to transfer the integrated 
BAC construct to their offspring. During the next step of this project, germline transmission 
has to be found by crossing out every individual BAC-injected fish to wild type fish until a 
founder has been found. Once the stable line has been created, Cdh5-loxP fish can be crossed 
to inducible Cre-driver lines, including heatshock:Cre and CreERT. The next step would be the 
optimisation of the Cre-based recombination by testing different heat-shock time durations or 
different concentrations of tamoxifen. Meanwhile, the Cdh5 BAC expressing fish should be 
crossed with Cdh5 mutant fish, to assure that the BAC is the only cdh5 gene present in the 
genome. 
 
4.1.6. Analysis of cytoskeletal junctional interactions during blood vessel morphogenesis 
Once a stable inducible Cdh5 knock-out line has been established, experiments to analyse the 
cytoskeletal interactions during vessel morphogenesis can be performed. First, the dependence 
of ECs on Cdh5 can be observed by analysing EC behaviour during different embryonic stages. 
This includes time-lapse imaging of ISV sprout outgrowth and anastomosis in endothelial 
marker lines, when cdh5 is removed around 24hpf or 30hpf respectively. Another important 
aspect would be whether removal of cdh5 still allows cell rearrangements during the formation 
of unicellular tubes into multicellular tubes. During this time frame, lumen formation can be 
analysed as well, since heart functioning and blood flow should be established normally. The 
inducible knock out line will also allow analysis of Cdh5-dependent EC behaviour at later time 
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points beyond 50hpf: Does arterial to venous transformation still occur or do ISV stay in a 
unicellular configuration? Can ECs in the aorta still adapt their configuration to differences in 
blood pressure and shear stress? 
To what extend the expression of the BAC will be mosaic, depends on the localisation of its 
integration in the genome as well as post-transcriptional regulation. The tension sensor line, 
which is also based on the Cdh5 BAC, is expressed in a non-mosaic way (Lagendijk et al., 
2017). Depending on the purpose, the amount of mosaicism can manipulated by activation of 
Cre. Either the duration of heat-shock induction could be shortened or, in case of a CreERT 
line, the concentration of tamoxifen can be lowered in order to obtain more mosaicism. 
Generating mosaic ECs with differences of Cdh5 amounts in each individual cell would be an 
important tool to analyse cell-cell interaction in more detail: Would JBLs still be formed in case 
the neighbouring EC could not contribute to adherens junction formation? To what extend is 
the motility of an EC dependent on its neighbour? Within mosaic sprouts one could investigate 
whether cell shuffling could take place in absence between ECs with different levels of Cdh5. 
Can a Cdh5-less cell still take over the tip cell position when a Cdh5 expressing tip cell has 
been removed? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
83 
 
4.2 Generation of a photoconvertible fluorescent protein-tagged Cdh5 line 
 
To examine to what extend individual neighbouring ECs contribute to the formation of JBL 
dynamics, I generated a photo-convertible fluorescence-tagged Cdh5 construct. In this project, 
the sequence encoding for mClav was introduced between the p120-catenin and β-catenin 
binding sites in the BAC containing cdh5. Introduction of this BAC construct in zebrafish, 
resulted in embryos expressing green mClav at the location of Cdh5 and exposure to 405nm 
blue light could convert the mClav signal to emission of red light. 
Having established the BAC recombineering technique and having generated a Cdh5 containing 
BAC with iTol2 sites and an eye marker already present in the backbone in favour of the 
inducible Cdh5 project, the establishment of a photoconvertible fluorescent protein-tagged 
Cdh5 construct could be made in one recombineering round. This demonstrates the value of the 
presence of a basic Cdh5 BAC with modified backbone in the lab. For further genetic editing 
on the cdh5 gene in future, one could always start from this BAC, saving a lot of time. 
The next step will be finding a founder that transmits the photoconvertible fluorescent protein-
tagged Cdh5 to its offspring, identical to 4.1.5. Once a stable line has been established, the Cdh5 
localisation of individual endothelial cells can be visualised. To that, specific ECs of interest 
can be exposed to blue light, converting their mClav into a red light emitting protein. Then, 
time lapse imaging can trace the localisation of Cdh5 and its contribution to adherens junctions 
with neighbouring cells whose mClav emits green light. With this tool, one could examine how 
JBLs are formed and to which extend a moving EC is dependent on Cdh5 presence of its 
neighbouring cell. This analysis will enable a description of actin-Cdh5 mobility in more detail 
to explain how ECs use Cdh5 to remodel and adapt to changes in growth and shear stress 
without losing the EC barrier. 
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4.3 Phenotypic characterisation of RadilB 
 
In this side project, the in vivo role of RadilB underlying vascular morphogenesis was for the 
first time investigated. Genomic analysis showed three Radil paralogues (RadilA, -B and -C) 
in the zebrafish genome. Via in situ hybridisation for each Radil paralogue, I showed that 
RadilB was endothelial specifically expressed. From cell culture experiments, we know that 
Rasip1 is not the only Rap1 effector, but cooperates with the closely-related Radil protein that 
shares three of its four protein domains with Rasip1, which prompted us to initiate phenotypic 
vascular analyses on RadilB mutant embryos. 
 
4.3.1. Efficiency of cellular rearrangements might be impaired in absence of RadilB 
RadilB KO fish showed intermittent lumen collapses of growing ISVs that only took place in 
arterial ISVs that converted to venous ISVs and simultaneously divided. It was already observed 
before that lumens in wild type unicellular vessels collapse during cell division (Aydogan et 
al., 2015). An increased amount of lumen collapses suggests that within RadilB homozygous 
mutants the amount of unicellular ISVs might be higher than in wild type. Contrary to the initial 
antibody stainings against Cdh5 at 32hpf, the Cdh5-marker line at later stages indicated that 
Cdh5 in RadilB mutant ISVs often show a detached pattern throughout the vessel (Figure 11C), 
illustrating a unicellular configuration. However, more samples at different time points of the 
Cdh5-marker line in RadilB mutants should be imaged and analysed to claim whether RadilB 
homozygous embryos possess more unicellular ISVs or that the process of cellular 
rearrangements into multicellular vessel is delayed.  
A delay in cellular rearrangement efficiency might not only explain a higher number of 
unicellular vessels, but might also explain the observed arterial to venous shunts, since the 
transforming initial arterial vessels might not be capable enough to rapidly detach itself from 
the DA and rearrange itself into a vein upon binding to the emerging secondary sprout. 
Another reason for more unicellular vessels during ISV formation could be a consequence of 
the observed decrease of endothelial cell divisions in RadilB homozygous mutants. On the other 
hand, mice and zebrafish lacking Rasip1 form smaller dorsal aortae (Wilson et al., 2013; Koo 
et al 2016). I have not yet quantified abnormalities in the dorsal aorta of RadilB mutants, 
however, a smaller dorsal aorta will most probably supply less cells able to sprout into ISVs, 
resulting in more unicellular vessels.  
 
4.3.2. RadilB does not control initiation of lumen formation but might control proper 
lumen expansion and rigidity 
Absence of Rasip1 in mice led to either absence of lumen formation (Xu et al., 2011) or initial 
formation of lumens that ultimately collapsed (Wilson et al., 2013). The RadilB mutant 
zebrafish in this study, however, demonstrated initial lumen formation that under certain 
circumstances collapse and reopen again, suggesting a more prominent role for Rasip1 in lumen 
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formation. Further research on Cre-lox mice proposed that Rasip1 induces lumen formation via 
activating Cdc42 activity and from the moment the lumen has been formed, facilitates lumen 
expansion via suppression of actin-myosin contractility by inhibiting RhoA (Barry et al., 2016). 
Since only Radil can bind Arhgap29 via its PDZ domain that subsequently inhibits RhoA (Post 
et al., 2015), these findings suggest that Rasip1 mediates vessel morphogenesis via a Radil-
dependent (via RhoA) and a Radil-independent (via Cdc42) pathway. In addition, Rap1 controls 
the endothelial barrier via Arhgap29, the inhibitor of RhoA (Post et al., 2013). Therefore, 
RadilB might not prevent lumen formation itself, but proper lumen expansion and rigidity might 
be disrupted due to the absence of RhoA inhibition and consequently excessive actin-myosin 
contractility.  
Apparently, lack of RhoA control allows collapsed lumens to reopen, but generates during the 
maturation of blood vessels an abnormal cell wall architecture (Figure 9C). In order to decipher 
different roles for Rasip1 and Radil during lumen formation in more detail, one could visualise 
the localisation of the apical marker podocalyxin in both mutant backgrounds, since 
podocalyxin indicates the localisation and the onset of lumen formation. I would expect that the 
spatio-temporal localisation of podocalyxin would be disrupted by the absence of Rasip1, rather 
than RadilB.  
 
4.3.3. Excessive actin myosin contraction on Cdh5 might hamper cellular 
rearrangements and cell motility 
Rasip1 has been shown to be indispensable for proper Cdh5 localisation (Koo et al., 2016). 
Also in RadilB homozygous mutants, aberrant Cdh5 localisation patterns were observed. Since 
RadilB activity inhibits actin myosin contraction via RhoA and since Cdh5 serves as an anchor 
point for the actin cytoskeleton, the Cdh5 mislocalisation may be a consequence of excessive 
actin tension. In addition, too much actin myosin contraction could prevent proper cell 
rearrangement and EC motility induced by Cdh5 necessary for transformation into multicellular 
vessels and to prevent arterial to venous shunts. Whether the loss of rearrangement capacities 
is due to excessive cytoskeletal tension could be examined using the Cdh5 tension sensor line 
(Lagendijk et al., 2018) and by rescuing the phenotype using the ROCK inhibitor Y-27632 that 
prevents further actin myosin contraction. 
 
4.3.4. RadilB’s function is probably restricted to RhoA-inhibition  
In order to decipher a RhoA-based role of RadilB, one could analyse vascular morphogenesis 
in Arhgap29 mutant embryos. In the zebrafish genome, two genes for Arhgap29 exist, from 
which arhgap29a expression is restricted to endothelium (Gomez et al., 2009). Comparison 
between the Arhrap29A phenotypes and the RadilB phenotypes will indicate whether RadilB 
plays either a role restricted to RhoA inhibition, or other Arhgap29- and Rasip1-independent 
roles. Also currently ongoing experiments on Heg1 morphants will elucidate more about to 
what extent Rasip1/RadilB complex formation on the one hand and Rasip1 and RadilB 
individually on the other hand contribute to blood vessel morphogenesis.  
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Another experiment that could elucidate more about whether the function of RadilB is restricted 
to Rasip1-RhoA pathway, would be the generation of a zebrafish line that expresses a truncated 
version of radilb that encodes for a RadilB protein lacking the PDZ domain. This line would 
show potential functions of RadilB independent of RhoA-inhibition via Arhgap29 as might be 
the case for Cdc42 activation by Rasip1. If one could show that the function of RadilB is 
restricted or RhoA-inhibition it could be used as a new tool for examining RhoA-induced actin-
myosin contraction during angiogenesis, thereby eliminating the use of the ROCK inhibiting 
compound. 
 
4.3.5. Redundancy between Rasip1 and RadilB 
Future experiments should focus on comparing Rasip1 (UBS28) and RadilB phenotypes to 
examine the level of redundancy and therefore the importance of their cooperating system for 
vascular morphogenesis. An important tool will be the generated antibody against RadilB to 
document RadilB’s presence at different stages of vascular development, which is currently in 
testing phase (cf. Appendix III). The phenotypic analyses of both Rasip1 and Radil will result 
in new insights about how EC behaviour is regulated at the level of small GTPases, enabling 
them to form proper blood vessels without losing their barrier function. 
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Figure A-I. Backbone modifications of the Cdh5 containing BAC in order to make it 
suitable for genome integration and screening for its expression. (A) In a first attempt to apply 
BAC recombineering for genomic editing, a construct containing inverted Tol2 sites and β-
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crystalline:mKate2 eye lens marker was exchanged for the first loxP site in the BAC backbone. In case 
of construct integration, the SW102 cells could survive on minimum plates containing ampicillin. The 
BAC of surviving cells was then purified and screened by PCR and correct recombination confirmed by 
sequencing. (B) Further in the backbone, a second LoxP site was present that had to be removed. This 
was done in a similar way as in A, thereby exchanging it for an AttB site, serving for phiC31 integrase-
mediated attP/attB recombination into attP landing sites, present in the genome of an attP-containing 
zebrafish line. Recombineered BACs were screened by PCR and correct ones confirmed by sequencing. 
The sequencing result showed, however, a C to T point mutation in base pair 29 of the AttB site. (C) In 
order to simplify PCR screenings in which UBS8 Cdh5 mutant fish should be distinguished from BAC 
Cdh5 inducible mutants, BAC Cdh5 exon 3 was removed by recombineering. The removal is 
demonstrated by PCR and sequencing. 
__________________________________________________________________________________ 
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Figure A-II. Trouble shooting BAC recombineering: unstable biotin solution does not 
allow SW102 cell growth on minimal plates. After successfully performing BAC recombineering 
events over months, this technique encountered at some point some troubles: introduction of the galK 
gene into the BAC did not allow growth of any cells on galactose-containing minimal plates anymore. 
To find out which element caused a problem, the technique was divided into its four components, 
whereupon each component was tested individually. The tests were performed based on the exchange 
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of the galK gene for exon 2, since this had been demonstrated to work before (Figure 1C). (A) The first 
component is the BAC itself. To test whether the BAC was still intact, XbaI digest was performed on 
the BACs during their different designal stages. The results are depicted in Figure 3A. and show that the 
used BACs must be correct (B) The second component is the insert containing the desired modification 
of the BAC, in this case the galK gene flanked by 50bp-homology arms. PCR was performed on a freshly 
linearized galK plasmid and the design of its primers were rechecked. Synthesis of the insert by PCR 
was checked by electrophorese and sequencing. All PCR reactions were always followed by DpnI 
treatment to get rid of the DNA template. All results indicated that nothing was wrong with the insert. 
(C) The third component were the SW102 cells. After transformation with the galK insert, the cells 
could grow on standard agar plates with chloramphenicol, on MacConkey plates as well as on Deoxy-
galactose-containing minimal plates indicating that the SW102 cells did not die during the procedure to 
make them electro-competent and/or during transformation. On minimal plates containing galactose, 
however, none of the cells did survive. Maybe the SW102 cells lose their recombineering efficiency 
over time: they were already used for multiple generations and their recombineering facilitating proteins 
might also cause mutations in their own genes after each generation. Therefore, a new stock of fresh 
SW102 cells was ordered and transformed with the Cdh5 BAC. Nevertheless, none of the new SW102 
cells survived on galatose-containing minimal plates. Presumably, the cells were still working, but the 
plate composition was not optimal anymore. (D) The fourth component were the minimal plates. The 
plates were remade as described in paragraph 2.2.2. from freshly made solutions of all ingredients. Non-
recombineered BAC-transformed SW102 E. coli were plated on standard agar, MacConkey and the two 
minimal plates and could survive on all of them except the galactose containing one. The latter was 
expected since no galK gene had been introduced yet. Given the observations that Galk-transformed and 
non-transformed SW102 could survive on deoxy-galactose containing plates, the components of the 
minimal plates sufficed for cell growth. The only difference between both minimal plates was the 
presence of either galactose or deoxy-galactose respectively. Therefore, new galactose powder was 
ordered and instead of autoclaving its solution, a sterile filter was used to keep the galactose as intact as 
possible. Still, minimal plates containing the newly prepared galactose did not allow cell growth, even 
when the BAC-containing cells were transformed with the original galK plasmid. Further attempts to 
optimise the plate’s composition led to, amongst others, ordering new biotin powder from which a fresh 
biotin solution was made. Indeed, when the fresh bought biotin was used, galK transformed SW102 
cells could survive on the galactose-containing minimal plate. Apparently, biotin does not restrict 
completely the survival on deoxy-galactose-containing plates. Further literature research on biotin 
revealed that it only stays stable in solution at 4°C up until 4 months. These requirements of biotin’s 
stability were neither initially respected, nor reported in earlier existing BAC recombineering protocols. 
__________________________________________________________________________________ 
 
 
 
 
 
 
 
95 
 
 
 
Figure A-III. Generation of an antibody against RadilB. (A) The protein sequence of RadilB 
was analysed for potential peptide candidates against which antibodies could be generated. To this 
purpose, alpha helices and beta sheets (indicated as H en E) are not suitable for triggering an immune 
response. Further, functional domains (indicated in green) were excluded since the domains are not 
unique to RadilB. Glycosylation site (green) as well as more than 3 hydrophobic amino acids in a row 
(blue) should be avoided for efficient antibody generation. Ideally, a peptide consist of 10 to 20 amino 
acids, contains less than 3 prolines and glutamines, no cysteines, no N-terminal glutamine or  asparagine 
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and no C-terminal proline or glycine. When respecting the above requirements, six possible peptide 
candidate can be identified from RadilB’s protein sequence. Two of them were found as well using an 
algorithm for identifying peptides by the antibody generating company (Eurogentec). Other proposed 
peptides from the algorithm were located partially in functional domains. The two chosen peptides were 
synthesised, injected into rabbit and purified by Eurogentec. (B) Preliminary results visualising the 
RadilB protein localisation using the generated antibody in 32hpf kdrl:gfp embryos. RadilB seemed to 
be endothelial specific and its localisation pattern showed a high similarity to the one of Rasip1 and 
Cdh5 (cf. Figure 11A). 
__________________________________________________________________________________ 
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